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Physicians educated in one country can practice in another be-
cause medical education and professional credentialing have become
more standardized. Hospital chains can open branches in places as dis-
parate as North America and Southeast Asia because more governments
are opening their health sectors to foreign investment. The same phar-
maceuticals and medical devices can be procured all over the world be-
cause groups like the International Conference on Harmonization and the
Global Harmonization Task Force have helped harmonize regulatory re-
quirements. And patients increasingly feel comfortable having invasive
surgeries overseas because organizations like Joint Commission Interna-
tional and the International Organization for Standardization have proc-
laimed that certain hospitals meet internationally recognized standards.
How do we explain these recent international trends? What do
we make of widespread physician emigration, or the growing phalanx of
international hospital chains? Why have global sales of pharmaceuticals
and medical devices grown by hundreds of billions of dollars in less than
a decade? How do we explain the hundreds of thousands of patients that
now seek medical treatments in foreign jurisdictions? And why is the
health care industry increasingly outsourcing clinical trials, insurance
claims processing, diagnostic test interpretations, and other tasks over-
seas?
In this article, I articulate a theory that helps explain the envi-
ronment in which these trends have emerged. Although no single theory
can fully account for these trends, I argue that they have all been enabled
by growing "convergence" in the health care industry. Utilizing a new
theory that I label "market-driven convergence," I show that various me-
thods, practices, and standards in the health care industry are converg-
ing--or becoming more alike across jurisdictions. For example, there
are internationally recognized uses of many drugs and antibiotics. Hos-
pital quality standards are spreading. The expectations for doing busi-
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ness in health care are becoming more universal. And basic principles of
scientific medicine are being taught. Modern medicine is converging.
In this article, I also demonstrate that convergence is being dri-
ven primarily by the private, rather than the public, sector. Private enti-
ties push for convergence because they benefit from it. Furthermore, the
market provides incentives to eliminate inconsistencies.
Thus, this article attempts to establish a conceptual framework
for understanding market-driven convergence, explains how it facilitates
international trade in health care, and considers the implications-both
good and bad.
Until now, health scholars have focused primarily on "policy
convergence" in the public sphere. For over thirty years, scholars have
asked whether policymakers emulate those in other jurisdictions, and
whether health system reforms have followed the same general trends.
For example, in 1994, the Organization for Economic Cooperation and
Development (OECD) analyzed health system reforms in seventeen
countries, finding that later reforms generally borrowed policies and in-
novations from earlier reforms.' Several other scholars have found evi-
dence of public policy convergence in health care.
But what about the private health care sector? If public sector
convergence warrants study, we should also investigate private sector
convergence. In this article, I formulate a conceptual framework for
thinking about private, market-driven convergence in health care. Given
this framework, I consider the evidence for and against market-driven
convergence before evaluating the benefits and burdens it presents. I
conclude that although market-driven convergence generates many tang-
ible benefits, it may do so at the expense of the already overburdened
public health care systems in many countries.
I begin in Part I by discussing theories of public policy conver-
gence in health care, the focus of most of the literature on convergence.
In Part 1I, I utilize lessons from policy convergence to develop a concep-
tual framework for understanding market-driven convergence and dis-
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cuss key differences between the theories. This section then evaluates
several trends that illustrate market-driven convergence in action and
concludes by addressing the arguments against convergence. In Part III,
I explore the potential benefits and burdens of market-driven conver-
gence. If methods, practices, and standards in the health care industry
are converging internationally, what are the implications? First, I discuss
the potential benefits of market-driven convergence, including increased
efficiency in health care markets, gains from trade, higher quality goods
and services, and enhanced patient choice and autonomy. However, I al-
so weigh these potential benefits against the very real risks that market-
driven convergence will undermine public health care. Market-driven
convergence may not only exacerbate resource disparities in health care,
but may also result in lower quality health care for low-income patients.
Throughout the article, I pursue two themes. First, I note, where
applicable, how the United States has promoted market-driven conver-
gence and explain the pitfalls of converging towards America's unique
brand of health care. Second, I discuss how the potential benefits and
burdens of market-driven convergence are particularly acute for develop-
ing countries, where the scramble for finite health care resources is even
more desperate.
I conclude that although market-driven convergence presents
several concrete benefits, these benefits may accrue disproportionately to
the private sector at the expense of public programs. Therefore, I argue
that policymakers should be wary of the risks of conforming to interna-
tional, market-driven standards, particularly if it encourages their health
care sectors to further privatize and commercialize.
Thus, this article establishes a conceptual framework for consi-
dering convergence in the private health care sector, using theories pre-
viously constructed for the public sector. Even though we have difficulty
precisely delineating the public from the private in health care, some ac-
tivities do tend to fall in either camp. I intend this article not only to help
us understand the environment surrounding some significant internation-
al trends in health care, but also to evaluate the benefits and burdens of
this environment.
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I. THEORIES OF PUBLIC POLICY CONVERGENCE
The idea that modern societies are becoming more similar, or
"converging," is an old one.2 Observers have long noticed that policy-
makers tend to emulate one another, borrowing particularly useful or
clever innovations from their counterparts in other jurisdictions.' Mod-
ern travel and communications obviously accelerate this trend.4
Although convergence theories have gained popularity in recent
years,5 they have always been particularly appealing in health care.6
Health is one of our most fundamental values-it transcends geographi-
cal, political, and cultural boundaries.7 Most countries also struggle with
the same challenges in health care: How do we provide quality care, to as
many people as possible, for a reasonable price? Moreover, modern
science and medicine have gradually influenced how most countries or-
ganize, manage, and provide health care.8
These commonalities invite theories of convergence. If policy-
makers face similar challenges, why wouldn't they adopt somewhat simi-
2 See generally David Mechanic, The Comparative Study of Health Care Delivery Systems, I ANN.
REV. Soc. 43, 61 (1975) (discussing convergence of health care delivery systems in postindustri-
al societies); William Form, Comparative Industrial Sociology and the Convergence Hypothesis,
5 ANN. REV. SOC. 1, 5 (1979); CLARK KERR, THE FUTURE OF INDUSTRIAL SOCIETIES:
CONVERGENCE OR CONTINUING DIVERSITY? 3 (Harvard Univ. Press 1983).
3 Mark G. Field, Comparative Health Systems and the Convergence Hypothesis: The Dialectics of
Universalism and Particularism, in HEALTH CARE SYSTEMS IN TRANSITION: AN
INTERNATIONAL PERSPECTIVE 35, 37-38 (Francis D. Powell & Albert F Wessen eds., Sage Pub-
lications 1999); Colin J. Bennett, What Is Policy Convergence and What Causes It, 21 BRIT. J.
POL. Sci. 215, 220-23 (1991).
4 See Field, supra note 3, at 38: David Mechanic & David A. Rochefort, Comparative Medical
Systems, 22 ANN. REV. Soc. 239,239-40, 248 (1996).
5 A brief search shows recent convergence scholarship in a wide variety of areas, including: con-
stitutional law, Vicki C. Jackson, Constitutional Comparisons: Convergence, Resistance, En-
gagement, 119 HARV. L. REV. 109 (2005); corporate law, Chi-Wei Huang, Worldwide Corporate
Convergence within a Pluralistic Business Legal Order: Company Law and the Independent Di-
rector System in Contemporary China, 31 HASTINGS INT'L & COMP. L. REV. 361 (2008) and Ke-
nichi Osugi, What is Converging? Rules on Hostile Takeovers in Japan and the Convergence
Debate, 9 ASIAN-PAC. L. & POL'Y J. 143 (2007); voting rights law. Christopher Manfredi &
Mark Rush, Electoral Jurisprudence in the Canadian and U.S. Supreme Courts: Evolution and
Convergence, 52 McGILL L. J. 457 (2007); and labor law, Bridging the Past and the Future: A
Symposium on Comparative Labor Law, Part 11: Convergence or Divergence?. 28 COMP. LAB.
L. & POL'Y J. 443-500 (2007).
Robert Blank & Viola Burau, Setting Health Priorities Across Nations: More Convergence than
Divergence?, 27 J. PUB. HEALTH POL'Y 265, 267 (2006).
7 Richard L. Guerrant & Bronwyn L. Blackwood, Threats to Global Health and Survival: The
Growing Crises of Tropical Infectious Diseases-Our "Unfinished Agenda, " 28 CLINICAL
INFECTIOUS DISEASES 966, 966 (1999).
8 Mechanic, supra note 2, at 61-62.
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lar solutions? If the tenets of modern medicine have truly spread, why
wouldn't health care policies and practices become more alike?
In this section, I consider the theories of public policy conver-
gence that have developed over the last thirty years. Examining these
theories and how they have evolved help us to understand how conver-
gence might occur in the private sector.
A. THE BASIC THEORY OF CONVERGENCE
Over thirty years ago, in an article titled "The Comparative
Study of Health Care Delivery Systems," David Mechanic argued that
certain features of health care systems around the world were converg-
ing.9 Building upon broader theories that modern societies were gradual-
ly converging, Mechanic argued that science, technology, and other
broad sociological patterns were driving countries to adopt common so-
lutions to common health care problems "despite strong ideological dif-
ferences."'" Since that time, other political scientists, sociologists, and
health scholars have argued that health care systems are converging,
pointing to various trends in health care policies, practices, organization,
and/or management.
The basic theory of convergence is that health care systems are
becoming more alike." Scholars have focused the most attention on ex-
amining policy convergence-the hypothesis that formal policies, regula-
tions, and the organization of health care systems are converging. Policy
convergence theories argue, in general, that as countries develop and
modernize, their health care systems and policies gradually converge. 12
Many health policy analysts and economists have gathered evi-
dence supporting the policy convergence hypothesis. 3 For example, Ro-
bert Blank found that basic policy priorities are converging international-
ly, although the specific content and preferred instruments of these
policies still tend to diverge in practice."
9 Id.
'0 Id. at 61.
" Blank & Burau, supra note 6, at 266.
12 Id.; Bennett, supra note 3, at 217.
13 Richard B. Saltman, Convergence Versus Social Embeddedness, 7 EUROPEAN JOURNAL OF
PUBLIC HEALTH 449, 449-450 (1997) (summarizing various studies); Mechanic & Rochefort,
supra note 4. at 252-53 (describing different types of convergence).
14 See generally Blank & Burau, supra note 6.
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Nevertheless, given the breadth of the convergence hypothesis
and the resulting diversity of claims, it is always important to ask: What
exactly is converging? 5 Is it health care policies 6 or policy objectives? 7
Is it health care financing? 8 Health system organization?' 9 Manage-
ment?2" Public versus private participation?2' Health insurance?2  Med-
ical education?23 Technology?24 Products?' Practice standards?
26
Although most scholars carefully limit their claims, "conver-
gence" obviously connotes different things in different contexts. As one
observer notes, convergence "is not a coherent theoretical position," but
"is a complicated package of different trends and processes reflecting a
variety of theoretical and epistemological claims.
27
Among the different claims of convergence, health scholars have
devoted by far the most attention to policy convergence. One theory is
that science, technology, and capitalism are driving policy convergence,
not just in the health care sector, but in industrial societies at large.28
Another theory is that health policies have generally followed the devel-
opment of modern medicine.29 A common theme is that countries mimic
15 See, e.g., id.
16 See, e.g., Brian Abel-Smith, Health Reform: Old Wine in New Bottles, I LONDON SCHOOL OF
ECONOMICS HEALTH 7-9 (1995); David Wilsford, States Facing Interests: Struggles over Health
Care Policy in Advanced Industrial Democracies, 20 J. HEALTH POL. POL'Y & LAW 571, 578
(1995); See Mechanic & Rochefort, supra note 4.
17 See, e.g., Jeremy W. Hurst, Reforming Health Care in Seven European Nations, HEALTH AFF.,
Fall 1991, at 7, 8-9 (1991); Mechanic & Rochefort, supra note 4.
'8 See, e.g., Dov Chernichovsky, Health System Reforms in Industrialized Democracies: An Emerg-
ing Paradigm, 73 THE MILBANK Q. 339, 340 (1995).
19 See, e.g., id.; Diane Gibson & Robin Means, Policy Convergence: Restructuring Long-Term
Care in Australia and the UK, 29 POL'Y & POL. 43 (2001) (discussing Australia and United
Kingdom); Mechanic, supra note 2, at 61-62.
20 See, e.g., Chernichovsky, supra note 18, at 340; Stephen Harrison, Michael Moran & Bruce
Wood, Policy Emergence and Policy Convergence: The Case of 'Scientific-Bureaucratic Medi-
cine' in the United States and United Kingdom, 4 BRIT. J. POL. & INT'L REL. 1 (2002).
21 See, e.g., Hurst, supra note 17, at 19-20: JOSEPH WHITE, COMPETING SOLUTIONS: AMERICAN
HEALTH CARE PROPOSALS AND INTERNATIONAL EXPERIENCE (1995) (comparing how the Unit-
ed States relies primarily on private financing while most of our peer countries, including Aus-
tralia, Canada, France, Germany, Japan, and the United Kingdom rely on public financing).
22 See generally Hurst, supra note 17; WHITE, supra note 21, at 5-6, 61-90 (describing the basic
health insurance models established by Canada and Germany).
23 See, e.g., Mechanic, supra note 2, at 46-47.
24 See, e.g., Field, supra note 3, at 39, 40; Mechanic, supra note 2, at 46.
25 See, e.g., Mechanic, supra note 2, at 46.
26 See, e.g., Field, supra note 3, at 40-42.
27 Bennett, supra note 3, at 230.
28 Saltman, supra note 13, at 449; Field, supra note 3, at 35-37.
29 See Mechanic, supra note 2. at 61-62.
Vol. 26, No. 3
Wisconsin International Law Journal
each other because they face similar obstacles-how to afford health
care, how to provide it to as many people as possible, and how to make
sure that it meets certain quality standards." Many countries also face
aging populations, escalating health care costs, and rising patient expec-
tations.3'
Theories of policy convergence were reinvigorated in the late
1980s and early 1990s when several countries either proposed or imple-
mented health system reforms. Scholars and policymakers began to
compare these reform efforts, benchmarking other countries' experiences
and drawing conclusions about health reform trends.3" As noted above,
the OECD identified broad policy convergence after analyzing health
care reforms in seventeen countries:
The most remarkable feature of the health system reform among the
seventeen countries is the degree of emerging convergence. Whether
intentionally or not, the reforms follow in the general direction of
those pioneered earlier in other countries.
33
After this round of convergence scholarship focusing on health
system reforms, scholars began to refine theories of convergence.' Co-
lin Bennett (1991), Dov Chernichovsky (1995), David Mechanic and
David Rochefort (1996), and Richard Saltman (1997) each improved
previous convergence theories. More recently, scholars have more ag-
gressively sought evidence of divergence (Blank, 2006), or criticized the
theoretical foundations of convergence theories (Marmor, Freeman, and
Okma, 2005).
The scholarship demonstrates not only that "convergence" can
mean different things in different contexts, but that it is multivariate and
often a matter of degree-the reality often lies somewhere between com-
plete convergence on one end of the spectrum and complete divergence
on the other. These refinements of convergence theories offer valuable
lessons that I use to develop a framework for understanding market-
driven convergence.
30 Blank & Burau, supra note 6, at 265.
31 id.
32 Saltman, supra note 13, at 449.
33 Organization for Economic Cooperation and Development, supra note I; see generally Mechan-
ic, supra note 2, at 61.
34 See Bennett. supra note 3 (1991), Chernichovsky, supra note 18 (1995), Mechanic & Rochefort,
supra note 4 (1996), and Saltman, supra note 13 (1997).
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B. CONVERGENCE IS A PROCESS
In 1991, Colin Bennett refined how we think of convergence in
several ways. First, he framed policy convergence as a process rather
than as a static comparison between two or more countries.35 He empha-
sized that convergence "should be seen as a process of 'becoming' rather
than a condition of 'being' more alike. '36 Bennett suggested that conver-
gence represents a "movement over time toward some identified com-
mon point."37
Second, Bennett identified five different types of policy conver-
gence. Countries may adopt (1) similar policy goals, (2) similar policy
content, (3) similar policy instruments, (4) similar policy outcomes,
and/or (5) similar policy styles.38 This helps us understand that conver-
gence comes in different forms, which is important to note when discuss-
ing an industry as varied and as complex as health care.
Third, building on this framework, Bennett also identified four
modes by which policies may converge (1) through emulation, (2)
through networking by "elites" in discrete policy communities, (3)
through international harmonization, and (4) through penetration by for-
eign actors and entities.39 Each mode helps us understand how policies
might converge and offers insights as to how private industry practices
might converge.
Health policies converge under Bennett's first mode via "emula-
tion:" policymakers borrow ideas from their counterparts in other juris-
dictions. But Bennett differentiated "emulation" from "diffusion. '
"Emulation" occurs when countries consciously copy or adapt practices
from other jurisdictions.4" "Diffusion" occurs when countries successive-
ly adopt similar policies or practices, with no evidence of conscious co-
pying or adaptation.42 In the private sector, "diffusion" might be more
prevalent than "emulation" given the nature of market competition, al-
35 Bennett, supra note 3, at 219.
36 Id.
37 Id. (quoting Alex Inkeles, Convergence and Divergence in Industrial Societies, in DIRECTIONS
OF CHANGE: MODERNIZATION THEORY, RESEARCH AND REALITIES 13-14 (Mustafa 0. Attir,
Burkhart Holzner, & Zdenek Suda eds., Westview Press 1981) (internal quotations omitted)).
I8 d. at 218.
'9 Id. at 220-229.
40 Id. at 220-21.
41 Id. at 220.
"2 Id. at 220-21.
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though it might also be less important to differentiate the two for the
purposes of understanding market-driven convergence.
Health policies converge under Bennett's second mode via "elite
networking" or "policy communities:" experts with shared experiences
formulate methods to deal with common problems.43 In health care, this
can occur through policy networks, scientific and/or medical networks,
and other international networks that are concerned about the same is-
sues. These networks exist in both the public and private spheres. For
example, below, I discuss the International Conference on Harmoniza-
tion (ICH), a partnership between public and private sector entities to
harmonize various pharmaceutical regulatory standards.
Health policies converge under Bennett's third mode through in-
ternational harmonization, which occurs when actors recognize their mu-
tual interdependence.' As Bennett describes, harmonization springs
from "a vague notion signifying a reliance on others for the performance
of specific tasks to ensure complete and successful implementation or to
avoid troubling inconsistencies."45 Relying on theories of international
relations and regimes, Bennett notes that harmonization requires local
actors to sacrifice short-term independence for long-term commit-
ments-as evidenced by organizations like the European Community
(EC) and the OECD.' The ICH is a good example of market-driven
convergence via international harmonization.
Finally, health policies may converge under Bennett's fourth
mode when foreign actors and entities penetrate domestically.47 This
type of convergence may be the most forceful, but also the most chao-
tic.48 Bennett found significant evidence of convergence when multina-
tional businesses successfully lobbied for a common regulatory frame-
work for their businesses and products.49 Business interests may be well
coordinated and well financed, and they can pressure governments to
conform to prevailing international or regional standards.' Here, Ben-
nett clearly contemplates foreign actors influencing domestic policy but
41 Id. at 224-25.
4' Id. at 225.
45 id.
46 Id. at 226.
41 Id. at 227.
41 ld. at 227-28.
'9 Id. at 228.
50 Id.
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foreign businesses also undoubtedly affect domestic, private sector activ-
ities as well.
C. REFINING THEORIES OF CONVERGENCE
During the mid-1990s, theories of policy convergence continued
to evolve. In 1995, Dov Chernichovsky argued that many health care
systems were converging towards a paradigm in which they financed
health care publicly but incorporated market principles of competition
and efficiency in providing health care goods and services." This para-
digm has been bolstered by the ongoing activities of multinational organ-
izations like the OECD, the World Health Organization (WHO), the
World Trade Organization (WTO), the World Bank, and regional trading
blocs.52 Chernichovsky revealed that even public health care systems
have gradually looked for market mechanisms to control rising costs.
In 1996, David Mechanic and David Rochefort identified six ma-
jor areas of health policy convergence, arguing that many countries have
tried to (1) control costs and increase the efficiency and effectiveness of
their health care systems, (2) promote health outside of their health care
systems, (3) reduce inequalities within their systems, (4) improve prima-
ry care, (5) improve patient participation and choice, and (6) link health
and social services. 3 Under the first category, many countries have im-
plemented policies to promote competition and other market based prin-
ciples in order to increase the efficiency and effectiveness of their health
care systems. 4  Under the fifth category, the health care industries in
many countries have been shaped by consumers' demand to choose
among providers and treatment options.5
In 1997, Richard Saltman argued that studies of convergence of-
ten focus on related but distinct phenomena, identifying convergence
within different parts of health care systems. 6 Saltman helps us recog-
nize that health care-perhaps more than other industry-includes a
51 Chernichovsky, supra note 18, at 347-48, 350 (noting that Australia, Italy, and Spain have
adopted this approach, while the United Kingdom, the Netherlands, and Israel were in the
process of doing so).
52 Blank & Burau, supra note 6, at 266.
53 Mechanic & Rochefort, supra note 4, at 253-61.
14 Id. at 254.
51 Id. at 259.
56 Saltman, supra note 13, at 450.
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staggering array of systems, actors, products, markets, and regulatory re-
gimes.
To sort these distinct phenomena, and to categorize different
types of health policy convergence, Saltman proposed a three-part
framework. First, "social" convergence reflects the extent to which
countries' underlying cultures, values, norms, and priorities converge."
Second, "political" convergence reflects the extent to which countries'
health care systems, institutions, and policy priorities converge. 8 This
includes the particular mix of public and private financing, varying regu-
latory priorities, and the balance countries have struck between equity
and efficiency. 9 Finally, Saltman identified "technical" convergence be-
tween countries' scientific and medical practices, institutional manage-
ment, and payment systems.'
Saltman's framework, thus, progresses from the highest level of
abstraction to the finest level of detail. This framework is necessarily
malleable. Furthermore, it marks the important distinction between "pol-
icies" and "practices."'" Saltman argues that at the most abstract level,
there is "some small movement" towards "social" convergence, but
countries' distinct value systems remain stable-"Swedes still treasure
security and equity, Germans emphasize order, while Americans prefer
aggressive individualism."6
D. CONVERGENCE OR DIVERGENCE?
More recently, scholars have increasingly sought evidence of
continued policy divergence. For example, in 2006, Robert Blank ana-
lyzed whether nine developed, capitalist countries converged or diverged
in rationing health care, given that demand for health care generally ex-
ceeds its supply. 3 Unsurprisingly, Blank found that along Saltman's
three-part framework, countries' broad policy goals tended to converge
in that countries rationed their scarce resources.' But Blank also found




60 Id. at 450-52.
61 id.
61 Id. at 450.
63 Blank & Burau, supra note 6, at 269-72 (analyzing Australia, Germany, Japan, the Netherlands,
New Zealand, Singapore, Sweden, the United Kingdom, and the United States).
64 Id.
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verged,65 observing that "different health care systems focus widely dis-
parate attention" on exactly how to ration health care-for example,
whether to use supply or demand-side tools or price versus non-price ra-
tioning.'
However, even Blank acknowledges that no health care system is
internally monolithic.67 Each system uses a combination of different me-
chanisms to ration health care, including decisions by central agencies
and ministries, decentralized regional entities, insurers, and down to in-
dividual hospitals or physicians.'
Finally, some scholars have criticized the theoretical foundations
of policy convergence and the process of comparative health policy scho-
larship. For example, in 2005, Ted Marmor, Richard Freeman, and
Kieke Okma argued that most health reform debates take place domesti-
cally, "largely free from the spread of foreign ideas."'69 They argue that if
countries consider similar policies, it is not because they consciously
copy one another, but because they engage in "parallel thinking" to solve
similar problems such as rising health care spending.7" Under Bennett's
framework, this would qualify as "diffusion" rather than "emulation."71
Marmor, Freeman, and Okma found "as much evidence of con-
tinued difference (or divergence) in national arrangements for the
finance, delivery, and regulation of health care as there is of increasing
similarity. 2 They make the frequent criticism that convergence cannot
be inevitable, or that the theory is "a kind of soft technological determin-
ism."7" Finally, they dispute the conventional wisdom that international
organizations like the European Union (EU), the WHO, the OECD, and
the World Bank influence domestic health care policymaking.74
65 Id.
66 Id. at 270-71.
67 Id. at 272.
68 Id.
69 Ted Marmor, Richard Freeman, & Kieke Okma, Comparative Perspectives and Policy Learning
in the World of Health Care, 7 J. COMP. POL'Y ANALYSIS 331, 337 (2005) (internal quotations
omitted).
70 id.
71 Bennett, supra note 3, at 220-21.
72 Marmor et al., supra note 69, at 338 (quoting a formal official from the OECD's health policy
unit as saying "[T]he delivery and finance of health care vary between nations more than any
other public policy.").
71 Id. at 337.
74 Id. at 337-38.
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E. LESSONS FOR MARKET-DRIVEN CONVERGENCE
From this varied body of scholarship we can derive several use-
ful lessons.
First, as Bennett notes, convergence is a dynamic concept that is
best understood as an ongoing process rather than a static snapshot of
two or more countries.75 Although convergence can mean different
things in different contexts, it should always connote a process rather
than a singular state of being. An organic, process oriented theory of
convergence allows us to account for new factors that may affect the ex-
tent to which policies and practices converge or diverge over time.
Second, convergence is multivariate-it will almost always de-
pend on multiple dependent and independent variables. If there is a trend
toward convergence, we can almost always ascribe the trend to multiple
causes. And convergence often manifests itself in many ways. Given
the nature of health care, trends will generally have multiple causes and
effects.
Third, scholars must carefully identify what is converging.
Health care is a unique animal. It typically involves both the public and
private sectors and a multiplicity of laws, regulations, industries, mar-
kets, and actors. Health systems and industries are not internally mono-
lithic.
Finally, convergence theories are generally easier to defend at
higher levels of abstraction, particularly when they allow for evidence of
continued divergence. The more specific, rigid claims can easily be un-
dermined by evidence of divergence or by the reality that causes and ef-
fects are not so easily identifiable. Even Marmor, Freeman, and Okma
acknowledge that the debate between convergence and divergence "is
one of degree rather than of kind."76 They recognize that "at the most
general level," similar countries will "develop broadly comparable ar-
rangements for health care."77
With these lessons in mind, I consider a new theory of market-
driven convergence.
75 Bennett, supra note 3, at 219.
76 Marmor et al., supra note 69, at 338.
71 Id. (emphasis in original).
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II. A NEW FRAMEWORK: MARKET-DRIVEN
CONVERGENCE
A. THE THEORY OF MARKET-DRIVEN CONVERGENCE
"Market-driven convergence" is the process by which the private
sector encourages practices and standards in the health care industry to
converge, or become more alike across jurisdictions. Private, profit
seeking businesses in health care increasingly benefit from convergence.
They operate more efficiently when international practices are standar-
dized. And new business opportunities arise from harmonization.
For example, Western hospitals can meet surging demand for
skilled medical professionals by importing them from developing coun-
tries where students are educated according to internationally recognized
criteria. Medical students in developing countries become more market-
able by receiving degrees that are recognized by hospitals and graduate
medical education programs in Western countries. Hospitals market
their international accreditations and certifications because it attracts cus-
tomers. Pharmaceutical companies save a staggering amount of time and
resources by conducting clinical trials that will satisfy multiple regulators
around the world rather than conducting separate trials for each jurisdic-
tion. In short, market forces are driving convergence. Private sector ent-
ities benefit from it. Supply and demand often necessitate it.
In this section, I propose a conceptual framework for market-
driven convergence. I argue that the private health care sector is driving
industry convergence internationally, and that this, in turn, might affect
policies and other formal instruments in the long run. I attempt to ex-
plain the salient features of this theory and place it within the existing
scholarship, examining how it both builds on, and departs from, the theo-
ries of public policy convergence that I discussed in Part I.
As a preliminary matter, any theory of convergence must ac-
count for both evidence of continuing divergence and the multivariate
nature of convergence. For example, if actors in separate jurisdictions
act similarly, we can virtually always differentiate their behavior in some
respect or at least attribute the similarities to several complicated causes
or coincidences. This caveat is particularly apt in health care, which is
populated by a staggering assortment of actors, markets, and overlapping
legal and regulatory regimes.
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Nevertheless, recognizing that convergence will always be
somewhat incomplete and multivariate should not paralyze us from dis-
cussing theories of convergence that specifically account for these com-
plicating factors. In this article, I argue that private sector activities are
causing industry practices and standards to converge. Obviously, one
cannot point to a single cause or manifestation of this trend.
Saltman's organizational approach supports this reality, recog-
nizing that health care convergence may be social, political, or technic-
al.7" Market-driven convergence is more technical than social or political
because it encompasses converging medical practices, standards, and
other industry activities.79 For example, Saltman found "substantial con-
vergence on many scientific medical matters," including the "appro-
priateness of using most pharmaceuticals."8 Market-driven convergence
may reflect (or even promote) a degree of "social" or "political" conver-
gence under Saltman's framework,81 but these connections are more atte-
nuated, and I do not argue for them here.
Saltman also makes the important distinction between converg-
ing policies and converging practices.8 2 Market-driven convergence
tends to represent the latter. It is worth noting that public policy conver-
gence is much more difficult to achieve than private sector convergence.
Policy convergence takes longer to manifest itself. Cumbersome politi-
cal processes may impede efforts by policymakers to conform to interna-
tional standards. Or there might not be sufficient reason to follow inter-
national trends given the significant transaction costs associated with
passing legislation or promulgating administrative rules. But these
processes do not constrain private actors.
Policy convergence may also be inherently more difficult be-
cause it occurs within vastly different political systems and is more sus-
ceptible to shifting political consensuses. For example, in 1995, New
Zealand followed the international trend and passed market based re-
forms in its health care system before subsequent ruling parties withdrew
those reforms.83 Private industry practices are not subject to the same po-
litical hurdles that might delay or even defeat efforts to converge.
78 Saltman, supra note 13, at 450.
79 Id. at 450-52.
'0 Id. at 451.
", Id. at 450-5 1.
82 Id. at451-52.
83 Blank & Burau, supra note 6, at 279.
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Importantly, my theory of market-driven convergence also ac-
knowledges that the line between the "public" and "private" sectors is
often blurred in health care. The public and private spheres overlap and
dissipate in health care perhaps more than in any other industry. Few, if
any, health care systems are internally monolithic. Every country has a
mix of public and private participants.' Indeed, no purely "private" or
purely "public" system has ever existed." There are an infinite number
of permutations for organizing, providing, financing, and regulating
health care.86 Thus, although it is still possible to differentiate "public"
and "private" activities, these activities increasingly occur in both
spheres. I simply note that private sector activities are gaining traction in
even the most "public" systems.
My theory of market-driven convergence also fits within Colin
Bennett's framework, which explains that policies converge through (1)
emulation, (2) networking, (3) harmonization, and (4) penetration from
outside actors and entities.87 Market-driven convergence may be perpe-
tuated through each mode, but distinguishing the modes is perhaps less
important in the private sector. For example, Bennett usefully distin-
guishes between "emulation" and "diffusion," but it is less vital to make
this distinction for market-driven convergence. 8 Private practices and
standards may converge via both emulation and diffusion, and it matters
not whether the convergence is intentional if encouraged by market in-
centives.
Networking and harmonization may also be very different in the
private than in the public sector. For example, harmonization may be
more haphazard and decentralized in the private sector, though no less
impactful. Most companies must conform their practices to do business
overseas. Bennett's fourth mode of convergence-domestic penetration
by foreign actors-might be the most powerful force in market-driven
94 Albert F. Wessen, The Comparative Study of Health Care Reform, in HEALTH CARE SYSTEMS IN
TRANSITION: AN INTERNATIONAL PERSPECTIVE, supra note 3, at 3, 12-13 ("[T]he systems of all
nations have at least some market-oriented characteristics and are constrained to some degree by
collective (governmental) action."); Wendy Ranade, Introduction, in MARKETS AND HEALTH
CARE: A COMPARATIVE ANALYSIS 1, 2 (Wendy Ranade ed., Addison Wesley Longman Ltd.
1998) ("All health systems are a mixture of public and private elements..
85 Chernichovsky, supra note 18, at 340.
86 See John Appleby, Economic Perspectives on Markets and Health Care, in MARKETS AND
HEALTH CARE: A COMPARATIVE ANALYSIS, supra note 84, at 34,41.
87 See generally Bennett, supra note 3.
88 Bennett, supra note 3, at 220-21.
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convergence, as companies take advantage of new opportunities in for-
eign health care markets.
It is worth noting that two trends are driving these opportunities.
First, many governments, particularly among developing countries, are
privatizing parts of their health care sectors and are opening their sys-
tems to foreign investment and other forms of foreign participation.89
Most health care systems have incorporated at least some market based
tools to increase competition and efficiency, which tends to invite more
private sector participation.' ° It is no coincidence that the United States'
health care system relies most heavily on these market principles among
developed countries and also invites the most private sector participation.
Second, health care "consumerism" seems to be spreading,9
based in part on privatization, and based in part on the rising demand
among patients to choose their providers and treatments.92 As a result,
many health care systems have tried to give patients greater freedom of
choice.93 These efforts also generally invite more private sector partici-
pation in health care. From a theoretical perspective, this development is
particularly interesting because once patients enjoy more choice and au-
tonomy it may be difficult for policymakers to rein in these privileges for
the sake of rationing or managing resources.
These trends have been accounted for in some convergence theo-
ries. Robert Blank recognizes that health care systems of all stripes are
increasingly adopting market mechanisms to ration health care re-
sources.' Yet, despite widespread adoption of market or quasi market
mechanisms, Blank thinks that "[i]t would be a mistake to interpret these
diverse changes as policy convergence."'95 In a similar vein, although
Blank recognizes that countries have converged in placing a high priority
on containing costs; their specific strategies to contain costs continue to
vary.' Overall, Blank concludes that even though countries must deal
with similar problems, they continue to adopt different strategies to deal
with these problems.97 In short, Blank acknowledges that public policies
89 See infra Part I.B.4.
90 Chernichovsky, supra note 18, at 347-48, 350; Mechanic & Rochefort, supra note 4, at 254.
9' See generally Mark A. Hall & Carl E. Schneider, Patients as Consumers: Courts, Contracts, and
the New Medical Marketplace, 106 MICH. L. REv. 643 (2008).
92 Mechanic & Rochefort, supra note 4, at 259.
93 Id.
94 Blank & Burau, supra note 6, at 272-273 (citing Ranade, supra note 84).
" Id. at 274.
96 Id. at 275.
9' Id. at 277.
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may converge at the broadest, "ideational" level, but holds that specific
policy instruments used to achieve these policy goals or ideas continue to
differ.98
Saltman also limits his claims of policy convergence: "Depend-
ing on the issue involved, one can find examples of convergence, of for-
mal convergence but practical divergence and of consistent diver-
gence."'  There will always be a mix of convergence and divergence.
Even within the United States, health care policies and practices can dif-
fer from state to state or even city to city. Nevertheless, in Saltman's
three-part framework, he found substantial convergence at the third level,
reflecting convergence among technical and scientific practices."° He
points to the growing standardization of medical procedures, the use of
pharmaceuticals, and the use of certain payment tools such as capitated
payments. 0'
My focus on health industry practices aligns with Saltman's
findings that although countries continue to employ different health care
policies, the practices and standards within the industry are converging
considerably." Thus, perhaps it is not surprising that the more flexible
aspects of health care more easily succumb to international market pres-
sures to converge, while the less flexible aspects-such as formal laws
and regulations-tend to remain embedded.
Thus, recognizing that convergence theories can be too determi-
nistic,1"3 I refrain from arguing that health care systems or practices will
cease to be distinctive."° Instead, I argue that-although proponents of
convergence and divergence are both correct' ° 5- there are several trends
that strongly suggest that standards and practices within the health care
industry are converging as a result of private sector activities. Indeed,
Mark Field has argued that health systems are converging because there
are now "universal means of medical production," deriving from re-
search, science, and technology."° For example, the standard use of an-
tibiotics or insulin is not constrained by geographical or national bounda-
9' Id. at 274.
99 Saltman, supra note 13, at 451.
100 Id.
101 Id.
102 Id. at 452.
103 Field. supra note 3, at 42.
104 Olaug S. Lian, Convergence or Divergence? Reforming Primar. Care in Norway and Britain, 81
THE MILBANK Q. 305, 307 (2003).
105 Saltman, supra note 13, at 452.
106 Field, supra note 3, at 39.
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ries.7 I extend this trend into a full-fledged theory of market-driven
convergence, by which the argument is made that the private sector is
driving convergence within the health care industry.
B. TRENDS SUPPORTING THE THEORY
The theory of market-driven convergence may appeal to us intui-
tively, but what evidence is there that the health care industry's standards
and practices are converging? And how is convergence being driven by
the private rather than the public sector? In this section, I discuss several
international trends that support the theory of market-driven conver-
gence, including trends among health care professionals, medical educa-
tors, hospitals, insurers, and medical products manufacturers." 8
In discussing these trends, I pursue two related themes. First, I
discuss how American medicine has influenced many of these phenome-
na, for both better and worse. Second, I describe how convergence has
influenced the health care industries in developing countries. Historical-
ly, developing countries have struggled to modernize their health care
sectors due to recessions, diseases, wars, and other large scale impedi-
ments. " However, the following trends demonstrate that many develop-
ing countries have begun to cultivate and modernize their health care
sectors, albeit with some troubling distributional consequences.
1. CONVERGENCE AMONG MEDICAL PROFESSIONALS, EDUCATION, AND
SCIENCE
The most significant evidence of market-driven convergence can
be found in international trends surrounding the practice of medicine.
Methods, standards, and practices have gradually converged due to the
mobility of medical professionals, harmonization of medical education,
and the diffusion of modern scientific medicine.
107 Id.
108 This is not to say that convergence is inevitable, or that each trend supporting it is equally robust.
Some trends are quite embryonic, and some may be fleeting. Nor is this a definitive empirical
study of each trend, as such an undertaking would require a much narrower analysis of each sep-
arate trend, focusing on a more well-defined group of countries. Rather, I provide a macro-
analysis of the various trends that, together, demonstrate how the private health care sector is
driving convergence.
'09 Mechanic & Rochefort, supra note 4, at 244 (citing R. DESJARLAIS, L. EISENBERG, B. GOOD, &
A. KLEINMAN, WORLD MENTAL HEALTH: PROBLEMS AND PRIORITIES IN LOW-INCOME
COUNTRIES (1995)).
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First, standards and practices are converging because medical
professionals increasingly emigrate. Although it is difficult to character-
ize this trend as purely a private sector phenomenon-given that medical
professionals are frequently educated and/or employed by the public sec-
tor-their mobility is driven by market demand for their services. The
worldwide demand for physicians, nurses, and other skilled health care
professionals clearly exceeds the supply, which creates incentives for
trade. In turn, widespread professional emigration has generally helped
standardize medical practices across jurisdictions.
The medical professions have become incredibly mobile. To
date, most of the global trade in health services has been the movement
of medical professionals, including physicians, nurses, researchers, pa-
ramedics, midwives, technicians, consultants, management personnel,
and other skilled professionals.1 ' One powerful example is the preva-
lence of international medical graduates in the United States. Of all phy-
sicians practicing in the United States, approximately one quarter were
educated overseas."' And the eight largest suppliers of physicians are
developing countries, including (in order of contribution): India, the Phil-
ippines, Cuba, Pakistan, Iran, Korea, Egypt, and China."2 Moreover,
nearly one-fifth of the faculty at American medical schools was educated
overseas." 3 Foreign educated nurses also comprise roughly 14 percent of
nurses practicing in the United States, again, many of whom relocate
from developing countries. 114
Other countries' medical professions are similarly diverse."5 For
example, in 2006, the WHO estimated that 34 percent of physicians prac-
ticing in New Zealand were trained abroad, 33 percent in the United
"0 Rupa Chanda, Trade in Health Services, reprinted in TRADE IN HEALTH SERVICES: GLOBAL
REGIONAL, & COUNTRY PERSPECTIVES 35, 37 (2002).
... THOMAS PASKO & DEREK R. SMART, PHYSICIAN CHARACTERISTICS AND DISTRIBUTION IN THE
US: 2004-2005 (AMA Press 2004); James A. Hallock, Stephen S. Seeling, & John J. Norcini,
Perspective: The International Medical Graduate Pipeline: Whether to Depend on IMGs to Re-
medy the U.S. Physician Shortfall Involves Global Ethical Considerations, HEALTH AFF., July-
Aug. 2003, at 94. 94.
2 Graham T. McMahon, Coming to America-International Medical Graduates in the U.S., 350
New Eng. J. Med. 2435, 2437 (2004); see also Aaditya Mattoo & Randeep Rathindran, Does
Health Insurance Impede Trade in Health Care Services? 14 (World Bank, Policy Research
Working Papers, Working Paper No. 3667. 2005), available at
http://papers.ssrn.com/sol3/papers.cfm?abstractid=770970.
"13 Mattoo & Rathindran, supra note 112, at 14 (citing data from M. Liu and H. Yamagata, Trends
Among Foreign Graduate Faculn, at U.S. Medical Schools, 3 AM. ASS'N OF MED. C. ANALYSIS
IN BRIEF 1 (2003), available at http://www.aamc.org/datalaib/aibissues/aibvol3-nol .pdf.)
"4 Id. at 15.
115 Id.
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Kingdom, 27 percent in the United States, 23 percent in Canada, 21 per-
cent in Australia, and 6 percent in France and Germany. " 6 The number
of foreign trained nurses was also significant: 21 percent in New Zeal-
and, 14 percent in Ireland, 10 percent in the United Kingdom, and 5 per-
cent in the United States." 7 And there are significant exporters as well;
Indian physicians are the best example, with large numbers of Indian
medical graduates practicing in Australia, Canada, the United Kingdom,
and United States." 8
Recent data also confirms that medical professionals tend to mi-
grate from less developed to more developed countries."9 For example,
physicians from Sub-Saharan Africa migrate to South Africa; they also
migrate from South Africa to Canada; from India to the United States,
the United Kingdom, and Canada; and from Pakistan to the United King-
dom and the United States. 2 ° Developing countries have always been
concerned about the "brain drain," but these concerns are growing with
physician shortages in many areas.' 2'
How does this evidence support market-driven convergence?
One obvious reason for the "brain drain" is that medical professionals in
developing countries increasingly meet Western standards, making them
ripe for export. For example, many developing countries are changing
their medical curricula to conform to North American or Western Euro-
pean standards, with some offering classes in English.'22 Unsurprisingly,
North American and Western European countries increasingly accept
foreign graduates into graduate medical education programs. Over a
quarter of all interns, residents, and fellows in the United States graduat-
ed from foreign medical schools.'23 Some graduates return home and
16 World Health Organization, Working Together for Health: The World Health Report 2006, at 98
(2006), available at http://www.who.int/whr/2006/en/.
117 Id. Note that Mattoo and Rathindran estimate a significantly higher proportion of foreign-
educated nurses in the United States than the WHO study.
118 Fitzhugh Mullan, Doctors for the World: Indian Physician Emigration, 25 HEALTH AFFAIRS
380, 381 (2006) (stating that over 59,000 Indian medical graduates, or 10% of all registered In-
dian physicians, practiced in these four countries).
'19 Hallock, Seeling, & Norcini, supra note 11, at 95.
120 id.
121 Id. at 95-96.
122 Christophe Segouin, Globalization in Health Care: Is International Standardization of Quality a
Step toward Outsourcing?, 17 INT'L J. FOR QUALITY IN HEALTH CARE 277, 277 (2005).
123 Physicians who did not attend a medical school in the United States or Canada are known as in-
ternational medical graduates (IMGs). To enter a GME program in the United States that is ac-
credited by the Accreditation Council for Graduate Medical Education (ACGME), IMGs must be
certified by the Educational Commission for Foreign Medical Graduates (ECFMG). John R.
Boulet et al.. The International Medical Graduate Pipeline: Recent Trends in Certification and
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some become board certified and practice in the United States before re-
turning.'24 For example, a large cohort of Indian physicians has recently
repatriated, and many Indians now believe that it is pass6 to claim that
India is suffering from a straightforward brain drain." 5 Pakistan also re-
ports that some physicians are returning.'26 Every time a health care pro-
fessional changes venues, he or she contributes to the converging prac-
tice of medicine.
The demand for Western trained professionals also contributes to
the converging practice of medicine, particularly in developing countries.
Hospitals around the world increasingly utilize large numbers of foreign
physicians. One striking example is Bumrungrad Hospital in Bangkok,
Thailand, a private hospital claiming over 200 physicians that were board
certified in the United States.'27 Several other hospitals in developing
countries promote the presence of physicians who were board certified
and practiced in the United States or other Western countries. 121 So eager
to put themselves on par with Western hospitals, more hospitals in de-
veloping countries are hiring personnel that meet internationally accepted
standards.
The second reason for market-driven convergence in the medical
profession is the growing harmonization of medical education. Albert
Wessen notes that "the content of medical curriculum differs only
slightly from country to country."'' 29 In 1999, the World Federation for
Medical Education published international standards for medical curricu-
la, with blessings from the WHO and the World Medical Association. 3'
Residency Training, 25 HEALTH AFF. 469,469 (2006); Graham T. McMahon, Coming to Ameri-
ca - International Medical Graduates in the United States, 350 NEW ENG. J. MED. 2435, 2435
(2004).
124 Mattoo & Rathindran, supra note 112, at 13.
125 Stephen Bach, International Migration of Health Workers: Labour and Social Issues 13, (Int'l
Labour Office, Geneva, Working Paper No. 209, 2003),
http://www.equinetafrica.orgfbibl/docs/BAChres300108.pdf.
126 Saad Shafqat & Anita K.M. Zaidi, Pakistani Physicians and the Repatriation Equation, 356 NEW
ENG. J. MED 442,442 (2007).
127 News Hour with Jim Lehrer, statement of Bumrungrad Hospital spokesman (PBS television
broadcast Feb. 21, 2005) (transcript available at http://www.pbs.org/newshour/bb/health/jan-
juneO5/thailand_2-21 .tml).
128 Healthbase, Hospitals, https://www.healthbase.com/hb/pages/hospitals.jsp (last visited Oct. 25,
2008). For example, the Raffles Hospital (Singapore), Piyavate Hospital (Thailand), the Wock-
hardt Hospitals chain, the Anadolu Medica Center (Turkey), and Hospital Punta Pacifica (Pana-
ma) promote the presence of physicians that were board certified in the United States.
129 Wessen, supra note 84, at 5.
1J0 J j.p. van Niekerk et al., WFME Global Standards in Medical Education: Status and Perspec-
tivesfollowing the 2003 WFME World Conference, 37 MED. EDUC. 1050, 1050 (2003); see also
World Federation for Medical Education, http://www.wfme.org/ (last visited Oct. 27, 2008).
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Medical education is also being standardized by the Institute for Interna-
tional Medical Education, which published Global Minimum Essential
Requirements to identify specific educational objectives for medical gra-
duates."31 What is interesting is not that these organizations have pub-
lished international standards, but that these standards "are already in-
fluencing national and regional systems of recognition and accreditation
of medical schools."'
3 2
Moreover, the Global Alliance for Medical Education has begun
to discuss harmonizing continuing medical education (CME)' 33 The
UK-Nordic Medical Educational Trust has developed a transnational
CME program involving the American Medical Association, the Alliance
for CME, the European Academy of Medical Training, the Norwegian
Medical Association, the Royal College of Physicians, and the World
Federation for Medical Education."3M It is notable that these efforts are
being promoted primarily by professional organizations.'35
The third reason why standards and practices in the medical pro-
fession are converging is the persistent spread of scientific medicine.
The biosciences have lead a revolution that is influencing nearly all as-
pects of health care, including the procedures, practices, technologies,
education, ideologies, and professional and organizational methods we
use."'36 Modern information, communications, and imaging technologies
are creating "a collective global health care knowledge base."'37 Odin
Anderson's study of six industrialized countries concluded that "[t]he
most astonishing observation may be that, regardless of country, scientif-
131 Hans Katie, Global Standards in Medical Education - An Instrument in Quality Improvement,
36 MED. EDUC. 604, 604 (2002); see also, Institute for International Medical Education,
http://www.iime.org/iime.htm (last visited Oct. 27, 2008).
132 Van Niekerk et al., supra note 130, at 1050.
133 For example, Global Alliance for Medical Education (GAME) has held several conferences to
harmonize CME standards throughout the world. See GAME. 12th Annual Meeting of the Glob-
al Alliance for Medical Education, "Harmonizing CME Systems Around the World"; and
GAME, 13th Annual Meeting of the Global Alliance for Medical Education, "Global CME
Harmonization 2.0: Strategy for the Future", http://www.game-cme.org/meetings/index.html
(last visited Oct. 26, 2008).
134 Jane Sarasohn-Kahn, Information and Communication Technology, in GLOBAL HEALTH CARE
MARKETS: A COMPREHENSIVE GUIDE TO REGIONS, TRENDS, AND OPPORTUNITIES SHAPING THE
INTERNATIONAL HEALTH ARENA 94, 99-100 (Walter W. Wieners ed., Jossey-Bass Inc. 2001)
[hereinafter GLOBAL HEALTH CARE MARKETS].
135 Dave Davis, Continuing Medical Education: Global Health, Global Learning, 316 BRIT. MED. J.
385, 388 (1998), available at http://bmj.bmjjournals.com/cgi/content/full/316/7128/385.
136 Wessen, supra note 84, at 4.
137 Sarasohn-Kahn, supra note 134, at 94.
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ic medicine seems to have created similar types of health services, facili-
ties, and personnel." '38
Thus, standards and practices within the medical profession are
converging due to mobile medical professionals, harmonized educational
standards, and the spread of modern scientific medicine. Of course, the
private sector is not solely responsible for these trends, but international
market forces undoubtedly have been key contributors.
2. CONVERGENCE AMONG HOSPITALS AND INSURERS
Recent international trends among hospitals and health insurers
also support the theory of market-driven convergence. The hospital and
health insurance industries are becoming increasingly international,
which should gradually spread the basic standards and practices they
employ. For example, Albert Wessen notes that "hospitals and clinics
throughout the world have similar goals and attempt to practice similar
methods of diagnosis and care."' 39 Many hospitals and insurers have be-
gun competing in foreign markets, which also drives convergence.
The best example of market-driven convergence is the increased
harmonization of hospital standards. Several groups have tried to create
international standards for health care quality. " For instance, in the pub-
lic realm, the EU evaluates the health care quality monitoring systems
across EU Member States. 4' In the private realm, the International So-
ciety for Quality in Health Care (ISQua) created an International Accre-
ditation Program to harmonize international health care standards and
accreditation processes.'42 ISQua also runs a federation of accreditors
called the Agenda for Leadership in Programs for Healthcare Accredita-
tion (ALPHA).'43 A group of countries led by New Zealand even estab-
lished a program for evaluating the accreditors themselves. "
38 ODIN W. ANDERSON, THE HEALTH SERVICES CONTINUUM IN DEMOCRATIC STATES 6 (1989).
139 Wessen, supra note 84, at 5.
140 Id.; Elma G. Heidemann, Moving to Global Standards for Accreditation Processes: The ExPeRT
Project in a Larger Context, 12 INT'L J. FOR QUALITY IN HEALTH CARE 227, 227 (2000).
14 ' Heidemann, supra note 140, at 227. The EU created the ExPeRT Project (External Peer Review
Techniques) in 1996 for this purpose.
142 Id. at 228-229.
143 K. Tina Donahue, Accreditation and Globalization, in GLOBAL HEALTH CARE MARKETS 81, 85
(Walter W. Wieners, ed., 2001).
144 Heidemann, supra note 140. at 227-228. This group is called "The Wellington Group" because
it was led by the New Zealand Council on Healthcare Standards, now the Health Accreditation
Program of New Zealand, in Wellington, New Zealand.
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More tangibly, hospitals and medical facilities around the world
increasingly demand some form of international, mutually recognizable
hospital accreditation. The demand has been met initially by Joint
Commission International (JCI), which has accredited approximately 140
hospitals and medical facilities worldwide.'45 The breadth of accredita-
tion is impressive. JCI has accredited facilities in thirty-three different
countries, including Brazil (15 facilities), China (5), India (11), Ireland
(11), Jordan (4), Mexico (3), Saudi Arabia (20), Singapore (13), Spain
(17), Thailand (22), Turkey (17), and one each in Egypt, Ethiopia, Indo-
nesia, Korea, and Pakistan."4 Furthermore, as I have casually observed,
the demand for JCI accreditation has spiked the past few years.
JCI essentially is an American entity, operated by the same pri-
vate organization that accredits hospitals in the United States-the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO). ' 47
Although neither JCI nor JCAHO regulate the quality or safety of medi-
cal care per se, accreditation generally signals that the hospital or facility
itself meets certain minimum standards. 14 8
The JCAHO and JCI stamp of approval carries significant
weight internationally. First, JCAHO and JCI are governed by the major
U.S. trade associations, including the American Medical Association, the
American Hospital Association, the American College of Surgeons, and
the American College of Physicians. 49 Second, hospitals around the
world covet JCI accreditation because it may help them apply for cover-
age from insurers in the United States and in other lucrative markets. 5 '
Finally, JCI's allure stems in part from the Joint Commission's quasi-
governmental status in the United States. Over forty years ago, Congress
granted JCAHO statutory authority to both establish and monitor com-
'41 Joint Commission International (JCI) Accredited Organizations,
http://www.jointcommissioninternational.org/23218/iortiz/ (last visited Oct. 26, 2008).
146 Id.
147 JCI was formed in 1994 by JCAHO and the non-profit arm of JCAHO, Quality Healthcare Re-
sources, Inc. In 1998, JCAHO formed a subsidiary, Joint Commission Resources, Inc. (JCR).
JCI is now a division of JCR. See The Joint Commission, A Journey Through the History of the
Joint Commission, http://www.jointcommission.org/AboutUs/joint-commission-history.htm
(last visited Oct. 26, 2008). JCI launched its international accreditation program in 1999 in re-
sponse to growing interest in worldwide accreditation and quality improvement.
148 John C. Goodman & Gerald L. Musgrove, Patient Power: Solving America's Health Care Crisis,
in HEALTH CARE LAW AND ETHics 1071, 1074 (Mark A. Hall et al eds., 2003).
149 Id. at 1073-1074.
"0 G.V.R.K. Acharyulu & B. Krishna Reddy, Hospital Logistics Strategy for Medical Tourism 6, 15
(Jun. 10, 2004) (unpublished manuscript on file with author).
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pliance with hospital standards. 1 ' Medicare, Medicaid, and countless
other third-party payors require hospitals to be accredited by JCAHO in
order to qualify for reimbursement.'52 JCI accreditation is separate from
JCAHO's, but it seems to carry the worldwide imprimatur that an accre-
dited facility meets U.S. government standards.
Apart from its accreditation function, JCI is beginning to play a
more active role in promulgating international hospital standards. In
2008, it plans to host a "Practicum on Quality Improvement and Accredi-
tation" for facilities throughout the Asia-Pacific region.' The stated
purpose of the practicum is to discuss "the best practices, standards, and
processes needed to deliver the gold-standard of care. '' "M JCI will also
hold practica in Europe, Latin America, and the Middle East.'55 These
sessions would represent "elite networking" under Bennett's frame-
work. 156
Aside from quasi-governmental organizations like JCI, several
private hospitals are responsible for globalizing the hospital industry. In
Singapore, the Parkway Group and the Raffles Medical Group operate
properties in Malaysia, India, Sri Lanka, and the United Kingdom."' In
fact, Gleneagles International, the international chain of the Parkway
Group, is now one of the largest private health care organizations in
Asia.'58 In India, the Apollo Group is both establishing and acquiring fa-
cilities in Malaysia, Nepal, and Sri Lanka.
59
U.S. based hospital chains have also expanded internationally.
Adventist Health International operates more than 500 Christian non-
'51 Social Security Amendments of 1965, Pub. L. No. 89-97, 79 Stat. 286, 326-27 (codified as
amended at 42 U.S.C. § 1395bb (2000). Hospitals accredited by JCAHO are "deemed" to be in
compliance with the conditions for participating in Medicare.
152 HHS regulations require hospitals and other facilities participating in Medicaid to satisfy "Medi-
care Conditions of Participation," which include JCAHO accreditation. See, e.g., 42 C.F.R. §
482.1 (2007); DEP'T. OF HEALTH AND HUMAN SERV., OFFICE OF INSPECTOR GEN., THE
EXTERNAL REVIEW OF HOSPITAL QUALITY: THE ROLE OF ACCREDITATION, 30 (1999), available
at http://www.oig.hhs.gov/oei/reports/oei-0l -97-00051 .pdf.
'53 Joint Commission International, Dubai Practicum 2008,
http://www.jointcommissioninternational.org/ 3 2 2 4 5 (last visited Oct. 26, 2008).
154 id.
155 Joint Commission International, Education, http://www.jointcommissioninternational.org/24165/
(last visited Oct. 26, 2008).
156 See generally Bennett, supra note 3.
57 Chanda, supra note 110, at 37.
158 David Diaz Benavides, Trade Policies and Export of Health Services: A Development Perspec-
tive, in TRADE IN HEALTH SERVICES: GLOBAL, REGIONAL, AND COUNTRY PERSPECTIVES 53. 67
(Nick Drager & Cesar Vieira eds., 2002).
159 Chanda, supra note 110, at 37.
Vol. 26, No. 3
Wisconsin International Law Journal
profit hospitals, including a flagship hospital in Malaysia. ° CHRISTUS
Health, based in Texas, now operates seven health care facilities in Mex-
ico.161 Many of these hospitals were specifically designed with interna-
tional standards in mind to cater to an increasingly international clientele.
Perhaps the best example of a hospital centered on international
standards is the Bumrungrad International Hospital in Bangkok, Thail-
and. Bumrungrad is a private hospital that caters to foreign patients. It is
managed by hospital administrators from the United States, Australia,
Singapore, Thailand, and the United Kingdom.'62 It was the first hospital
in Asia to be accredited by Joint Commission International.'63 And it is a
publicly traded company whose major investors are the large private
companies and a wealthy Thai family."6 Market incentives have led
Bumrungrad and other hospitals to adopt international standards and pur-
sue international accreditation.
Health insurers and managed care organizations are also doing
more cross border business, which may begin to harmonize traditionally
localized insurance practices. For example, some insurers in California
now cover treatments in Mexico under recent state legislation allowing
these arrangements.'65 Health Net, SIMNSA, and Blue Shield offer plans
with lower premiums and deductibles to patients living in the United
States who are willing to seek care by Mexican providers.'66 These plans
160 See Adventist Health International, http://www.adventisthealthinetnational.org (last visited Oct.
27, 2008); Penang Adventist Hospital, About Us, http://www.pah.com.my/about-us/index.asp
(last visited Oct. 27, 2008).
161 CHRISTUS Health I Facility Search, http://www.christushealth.org/FacilitySearchMain.aspx
(last visited Oct. 27, 2008).
162 Bumrungrad International Hospital, Management, http://www.bumrungrad.conoverseas-
medical-care/About-Us/management.aspx (last visited Oct. 27, 2008).
163 First Asian Hospital to Get International Accreditation - Bumrungrad Hospital Thailand,
http://www.bumrungrad.com/overseas-medical-care/About-Us/hospital.accreditation.aspx (last
visited Oct. 27, 2008).
164 Bumrungrad International Hospital , Factsheet, http://www.bumrungrad.com/overseas-medical-
care/about-us/factsheet.aspx (last visited Feb. 11, 2009).
165 Arturo Vargas Bustamante, Gilbert Ojeda & Xochitl Castafieda, Willingness to Pay for Cross-
Border Health Insurance Between the United States and Mexico, 27 (1) HEALTH AFFAIRS 169,
170 (2008) (describing California's Knox-Keene Act of 1998); Richard Marosi, Healthcare is
Migrating South of the Border, L.A. TIMES, Aug. 21, 2005, at Al; Sarah Skidmore, Cross-
Border Health Insurance is a Hit with Employers and Workers, SAN DIEGO UNION-TRIB., Oct.
16, 2005, at H 1.
166 Deborah Crowe, Andy Fixmer & Anne Riley-Katz, Health Net Expands Latino Outreach, L.A.
BUS. J., June 12, 2006, at 13; Sistemas Medicos Nacionales, S.A. de C.V. (SIMNSA), Our Com-
pany, http://www.simnsa.com/about.html (last visited Oct. 27, 2008); Marosi, supra note 165, at
Al; Skidmore, supra note 165, at HI; Access Baja Health Products for Small Groups - Blue
Shield of California, http://www.blueshieldca.conproducerlsmallgroupslproducts/health/baja/
(last visited Oct. 27, 2008).
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should encourage standards in the insurance and provider industries in
California and Mexico to begin to converge.
Some health insurers cover foreign hospitals and providers in
even more distant markets. For example, United Group Programs now
covers procedures performed at the Bumrungrad Hospital in Thailand. 67
Blue Cross Blue Shield and the British insurer Bupa insure patients
treated at the Wockhardt Hospitals in India. 6 ' The Henner Group, based
in France, specializes in providing health care insurance to expatriates,
multinational companies, and students studying overseas, with an inter-
national network of health care providers.'69 To make these arrange-
ments work, participating hospitals and insurers must conform their prac-
tices and standards to at least some extent.
Some insurers like Blue Cross Blue Shield maintain extensive
overseas provider networks, catering to customers that travel frequently.
The company's BlueCard Worldwide program maintains a global net-
work of hospitals, physicians, and other health care providers. 7 ' Aetna
now provides a "Global Benefits" program that covers treatments over-
seas. 7 ' A brief survey shows that international health insurance plans are
proliferating.' Again, an international network of providers requires
participants to create some international standards for doing business.
These trends, although relatively new, suggest that companies in
the hospital and insurance industries will increasingly do business over-
seas. Again, cross border business in these industries operates in tandem
with the diffusion and harmonization of industry standards and practices.
Companies are pushing de facto international standards, changing their
practices to conform to requirements in other jurisdictions. Thus, market
forces are encouraging convergence in these industries.
167 Daniel Yi, Overseas Surgery a Clamp on Costs, L.A. TIMES, July 30, 2006, at Al.
168 Ray Marcelo, India Hopes to Foster Growing Business in "Medical Tourism," FIN. TIMES, July
2, 2003, at 10.
169 See The Henner Group, GMC MedNet-The Medical Network, http://resmed.henner.coni/en (last
visited Oct. 27, 2008).
170 BlueCard Worldwide - When Traveling Outside of the U.S.,
http://www.bcbs.com/bluecardworldwide/index.html (last visited Oct. 27, 2008); See Mattoo &
Richardson, supra note 112, at 6 (explaining that the network is maintained by World Access
Service Corporation); See generally Mondial Assistance USA-Health Care,
http://www.worldaccess.cnm/en/aboutus/Products/health.htm (last visited Oct. 27, 2008).
17 Aetna, Aetna Global Benefits Homepage, http://www.aetnaglobalbenefits.com/default.jsp (last
visited Oct. 27, 2008).
172 See, for example, Global Insurance Net, http://www.globalinsurancenet.com/Default.asp (last
visited Oct. 27, 2008).
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3. CONVERGENCE AMONG MEDICAL PRODUCTS AND TECHNOLOGIES
International trends among medical products and technologies
support the theory of market-driven convergence. In recent years, not
only have the global markets for medical products surged, leading to
their widespread diffusion, but several of these industries have succeeded
in harmonizing international standards.
For example, the global pharmaceutical market both drives con-
vergence and benefits from it. Recent sales figures reflect the broad dif-
fusion of pharmaceuticals. The market grew by $41 billion in just one
year.'73 More importantly, since 2004, the primary increase in sales has
been in developing countries, mainly in Latin America, Asia, and Africa,
where markets have grown between 10 and 20 percent per year.74 In
2006, the global market grew 12.7 percent in Latin America and 10.5
percent in Asia and Africa. 175 Two important markets, China and India,
also grew significantly-sales in China jumped 20.5 percent in 2005 and
12.3 percent in 2006, and sales in India jumped 17.5 percent in 2006.176
Overall, 27 percent of growth in the global pharmaceutical market now
comes from countries with average annual incomes of less than
$20,000.171
The pharmaceutical industry's growth has been aided in part by a
coordinated effort to harmonize international standards. In 1990, phar-
maceutical regulators and industry organizations in the United States,
Europe, and Japan established the International Conference on Harmoni-
zation (ICH) to harmonize drug development and regulatory approval
standards. 78 ICH is composed of both regulators and industry represent-
atives. The regulatory members are the European Medicines Agency
(EMEA), the Japanese Ministry of Health, Labor, and Welfare, and the
173 Press Release, IMS Health, IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percent
in 2006, to $643 billion (Mar. 20, 2007), http://www.imshealth.com (type in the title of the press
release above in the search box, then click "search", then follow the first hyperlink) (the market
grew from $602 billion in 2005 to $643 billion in 2006).
174 Press Release, IMS Health, IMS Health Reports Global Pharmaceutical Market Grew 7.0 Percentin 2006, to $643 billion (Mar. 21, 2006), http://www.imshealth.com (type in the title of the press
release above in the search box, then click "search", then follow the first hyperlink).
175 Press Release, IMS Health, supra note 173 (the Asian numbers exclude Japan, which is already
the second largest pharmaceutical market in the world, behind the United States).
176 Id.
177 Id.
178 International Conference on Harmonisation of Technical Requirements for Registration of Phar-
maceuticals for Human Use (ICH), Homepage, http://www.ich.org/cache/compo/276-254- 
.html
(last visited Oct. 27, 2008).
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U.S. Food and Drug Administration (FDA). The industry representatives
include the Pharmaceutical Research and Manufacturers of America
(PhRMA), the European Federation of Pharmaceutical Industries and
Associations (EFPIA), and the Japanese Pharmaceutical Manufacturers
Association (JPMA).
According to ICH, its purpose is "to achieve greater harmoniza-
tion in the interpretation and application of technical guidelines and re-
quirements for product registration in order to reduce or obviate the need
to duplicate the testing carried out during the research and development
of new medicines."' 79 Although the regulators in these regions certainly
benefit from sharing information and harmonizing standards, it is the
companies that primarily benefit-not only because they save millions
upon millions in research expenses, but also because they can influence
the drug development requirements.
ICH is interested in broadening both the scope of its activities"
and its geographic reach. In 1999, ICH created the Global Cooperation
Group to communicate with regional harmonization groups outside
ICH. ' For example, ICH has invited participation from the Asia-Pacific
Economic Cooperation (APEC), the Association of Southeast Asian Na-
tions (ASEAN), the Gulf Cooperation Countries (GCC), the Pan Ameri-
can Network on Drug Regulatory Harmonization (PANDRH), and the
Southern African Development Community (SADC). 81 Additionally,
the WHO and Health Canada, the central Canadian public health agency,
are official observers to ICH.1
3
The pharmaceutical market also benefits from harmonization ef-
forts by other quasi-governmental bodies and industry organizations, in-
cluding the WHO's PANDRH,' 8 the Pharmaceutical Forum of the
Americas," 5 the International Pharmaceutical Federation (FIP),5 6 and the
179 id.
180 ICH, History and Future of the ICH, http://www.ich.org/cachelcompo/276-254-I.html (last vi-
sited Oct. 27, 2008).
'8' ICH, Frequently Asked Questions, http://www.ich.org/cache/compo/2834-272-1.html#4 (last
visited Oct. 27, 2008).
112 ICH, ICH Global Cooperation Group, http://www.ich.org/cache/comp/276-254-l.html (last vi-
sited Oct. 27, 2008).
183 ICH, supra note 18 1.
'8' Pan American Network for Drug Regulatory Harmonization (PANDRH),
http://www.panho.org/english/ad/ths/ev/RedParf-home.htm (last visited Oct. 27, 2008).
'85 Pharmaceutical Forum of the Americas, http://www.paho.org/English/ADTHS/EV/ffa-
home.htm (last visited Oct. 27, 2008).
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International Federation of Pharmaceutical Manufacturers Associations
(IFPMA),87 among others.
The global medical device market has enjoyed a similar trajecto-
ry, both in terms of sales and industry cooperation. The WHO predicted
that the medical device market would nearly double in just over five
years, growing from $145 billion in 2000 to over $260 billion in 2006.18s
Several years ago, the rapid growth of the device market spawned an ef-
fort to harmonize standards, similar to what the ICH accomplished for
pharmaceuticals.
In 1992, representatives from several regulators and industry or-
ganizations formed the Global Harmonization Task Force (GHTF) to
harmonize the regulation of medical devices.'89 The Task Force includes
representatives from the United States, the European Union, Canada,
Australia, and Japan."° It also meets with three related organizations: the
Asian Harmonization Working Party (AHWP), the International Organi-
zation for Standardization (ISO), and the International Electrotechnical
Commission (IEC).'9' The stated purpose of the Task Force is to "en-
courage convergence in regulatory practices" in addition to "promoting
technological innovation and facilitating international trade."' 92  The
Task Force publishes standards for basic regulatory practices that serve
as models for national regulators. 3
These international drug and device organizations have followed
the model of the ISO, an organization created in 1947 to develop world-
wide industrial and commercial technical standards."9 Technically, ISO
is a non-governmental organization, but its standards often become law
18' International Pharmaceutical Federation (FIP), http://www.fip.org/www2 (last visited Oct. 27,
2008). FIP is a worldwide federation of professional and scientific pharmaceutical organizations,
including those that represent pharmacists and pharmaceutical scientists. Id.
187 International Federation of Pharmaceutical Manufacturers & Associations,
http://www.ifpma.org/ (last visited Oct. 27, 2008).
188 WHO, Medical Device Regulations: Global Overview and Guiding Principles, at v, at
http://www.who.int/medical-devices/publications/en/MD-Regulations.pdf (2003) (calling medi-
cal devices "one of the fastest growing industries").
189 Global Harmonization Task Force: About GHTF, http://www.ghtf.org/about/ (last visited Oct.
27, 2008).
190 Id.
I91 d. "ISO" Is not an acronym for the International Organization for Standardization, but refers to
the Greek word 'isos', which means 'equal'. See ISO-Discover ISO: ISO's Name,
http://www.iso.org/iso/about/discover-iso isos-name.htm (last visited Oct. 27, 2008).
192 Global Harmonization Task Force, supra note 189.
193 Id.
194 ISO-Discover ISO: ISO's Origins, http://www.iso.org/iso/about/discover-iso isos-origins.htm
(last visited Oct. 27, 2008).
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domestically through treaties or other legal vehicles.'95 Currently, 157 of
192 countries in the world are members. 196 On its web site, ISO explains
how and why it established international standards:
When the large majority of products or services in a particular busi-
ness or industry sector conform to International Standards, a state of
industry wide standardization can be said to exist. This is achieved
through consensus agreements between national delegations
representing all the economic stakeholders concerned-suppliers, us-
ers and, often, governments. They agree on specifications and crite-
ria to be applied consistently in the classification of materials, the
manufacture of products and the provision of services. In this way,
International Standards provide a reference framework, or a common
technological language, between suppliers and their customers-
which facilitates trade and the transfer of technology.' 
97
Beyond drugs and devices, the markets for other medical prod-
ucts and technologies are similarly bullish and may be ripe for industry
driven standardization. For example, the global market for "telemedi-
cine" and "telehealth" is estimated to be $1.25 trillion and growing.'98
This market is made possible by cross border cooperation between health
care providers. Standardization might increase competition among tele-
medicine providers. Similarly, rapid growth in related industries, such as
private health insurance,"9  managed care,"°  insurance claims
195 Naomi Roht-Arriaza, Shifting the Point of Regulation: The International Organization for Stan-
dardization and Global Lawmaking on Trade and the Environment, 22 ECOLOGY LAW
QUARTERLY 479, 490 (1995).
196 ISO-ISO Members, http://www.iso.org/iso/about/iso-members.htm (last visited Oct. 27, 2008).
197 International Organization for Standardization, FAQs - General Information on ISO,
http://www.iso.org/iso/support/faqs/faqs-general-information_on_iso.htm (last visited October
21, 2008).
198 Ian S. Mutchnick, David T. Stern, & Cheryl A. Moyer, Trading Health Services Across Borders:
GATS, Markets, and Caveats, 24 HEALTH AFF. W5-42, W5-45 (2005) (web exclusive),
http://content.healthaffairs.org/cgi/reprint/hlthaff.w5.42vl.pdf.; Chanda, supra note 110, at 5.
This market includes "direct clinical services of $804.2 billion, professional back up services of
$22.5 billion, consumer health information related services of $21.6 billion, continuing profes-
sional education services of $3.9 billion, and management of health care delivery services of
$235.5 billion." Id.
199 See supra Part II.B.2. Some predict that the market for private insurance in developing countries
will "increase as more people move into income brackets that allow them to purchase private
health insurance." Mutchnick et al., supra note 198, at W5-47. See World Health Organization
[WHO], Commission on Macroeconomics and Health [CMH], Working Paper Series, Trade Li-
beralization in Health Insurance: Opportunities and Challenges: The Potential Impact of Intro-
ducing or Expanding the Availability of Private Health Insurance within Low or Middle Income
Countries, at 2, Paper No. WG 4:6 (Dec. 2000) (prepared by John A. Sbarbaro),
www.emro.who.int/cbilPDF/Healthlnsurance.pdf.
200 For example, by 1999, CIGNA covered 2.6 million people in Brazil, Chile, and Guatemala.
Aetna operates in Brazil via Sul America Seguros, which generated over $1 billion in revenues in
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processing,"' and clinical trials, 2 may lead to other coordinated efforts
to harmonize industry standards.
Of course, harmonization and convergence do not fully explain
why these industries have grown so dramatically. Another explanation is
that companies constantly introduce new products and technologies into
our health care systems."3 Typically, these new products are expen-
sive.24 Again, the pharmaceutical industry is instructive. A recent study
found that the United States not only spends much more per capita on
pharmaceuticals than several peer countries, but also uses newer drugs at
a much higher rate than most other countries that tend to rely on older
drugs with expired patents.2 5
The industries themselves benefit from these trends. They are
sustained by significant embedded interests, such as universities, medical
research centers, the medical professions, and of course, the manufactur-
ers. 2' A common criticism of these industries is that they artificially
drive demand for their products. 7 For instance, some scholars have
noted that the pharmaceutical and medical device industries "encourag[e]
rapid adoption often before efficacy or cost effectiveness has been dem-
onstrated.""2 8 Mechanic and Rochefort note that physicians and other
health care professionals often have strong incentives to use new tech-
nologies because they can generate additional income through higher
reimbursement and quicker amortization rates.2" They also note that pa-
tients and consumers in highly industrialized countries, particularly in the
United States and the European Union, also highly value the use of new
technologies.2"0
1996. Mutchnick et al., supra note 198, at W5-47. See Karen Stocker et al., The Exportation of
Managed Care in Latin America, 340 (14) NEw ENG. J. MED. 1131, 1133 (1999),
http://content.nejm.org/cgi/reprint/340/14/1131.pdf.
201 Chanda, supra note 110, at 6 n.5.
202 Richard A. Rettig, The Industrialization of Clinical Research, HEALTH AFF., Mar./Apr. 2000, at
129, 131, http://content.healthaffairs.org/cgi/reprint/19/2/129.pdf.
203 Field, supra note 3, at 39.
204 Id.
205 Patricia M. Danzon & Michael F. Furukawa, International Prices and Availability of Pharmna-
ceuticals in 2005, 27 (I) HEALTH AFF. 221, 221, 224 (2008),
http://content.healthaffairs.org/cgi/reprint/27/1/22 
.pdf.
206 Mechanic & Rochefort, supra note 4, at 243-44.
207 See id.; see Mechanic, supra note 2, at 46.
208 Mechanic & Rochefort, supra note 4, at 243.
2'09 Id. at 24344.
210 See id. at 244.
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Some developing countries have followed this trend. Many
middle-income countries now offer advanced medical procedures and
technologies, including some that have yet to be approved by Western
regulators like the U.S. Food and Drug Administration (FDA).211 Several
developing countries now boast state-of-the-art hospitals that compete to
attract foreign patients known as "medical tourists." '212 Many of these
hospitals conduct research to improve biotechnology products sold by
Western manufacturers.213
To attract patients, hospitals advertise the technologies they can
offer. For example, Wockhardt Hospitals in India advertises that it uses
"top of the line medical/diagnostic equipment" just like "hospitals in
New York, London, or Sydney. '214 Penang Adventist Hospital in Malay-
sia is General Electric's Southeast Asia test facility, "one of only a hand-
ful of facilities around the globe that receives the next generation of im-
aging equipment before the rest of the medical world. 21 5 Thus, even
developing countries use some of the same advanced medical technolo-
gies that were once offered solely by advanced industrialized nations.
In summary, some hospitals in developing countries now use the
same pharmaceuticals and devices used by elite Western hospitals. It is a
cyclical process. Manufacturers push for harmonization and conver-
gence to do business overseas and open new markets for their products.
In turn, developing economies seek to compete by adopting international
standards.
4. PRIVATIZATION, COMMERCIALIZATION, AND AMERICAN MEDICINE
Finally, three related trends support the theory of market-driven
convergence. First, health care has become more privatized around the
world. Second, health care goods and services have become more com-
mercialized. And third, American medicine has exported itself particu-
larly well. Together, these trends have allowed the private sector to exert
more influence in creating international practices and standards. In this
211 See Linda F. Powers. Leveraging Medical Tourism. THE SCIENTIST, Mar. 2006, at 79 (noting that
many patients are seeking stem cell and cancer treatments overseas that have not been approved
by FDA).
212 Nathan Cortez, Patients Without Borders: The Emerging Global Market for Patients and the
Evolution of Modern Health Care, 83 IND. LJ. 71. 82-85 (2008).
213 Powers, supra note 211. at 79.
214 Wockhardt Hospitals, International Patient Services,
http://www.wockhardthospitals.net/general/int-patients.asp (last visited Oct. 22, 2008).
215 Eric P. Erickson, Over the Ocean, Under the Knife, CHI. SUN TIMES, Nov. 27, 2005, at C1.
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section, I discuss how these three related trends have driven conver-
gence.
But first, it is first important to note that market-driven conver-
gence is part of a self-reinforcing cycle. The more countries privatize
and commercialize their health care sectors, the more the private sector
can influence industry methods, practices, and standards. And the more
the private sector, rather than the public sector, influences methods, prac-
tices, and standards, the more health care becomes privatized and com-
mercialized.
Although the trends of privatization and commercialization are
incredibly broad, they are not accidental. They reflect the various suc-
cesses of (1) free market economists, (2) pro-capitalism organizations in
the United States, (3) international organizations like the World Bank,
WTO, and OECD that push for trade liberalization, (4) private industry,
and (5) groups in developing countries that wish to open their health sec-
tors to foreign investment.
None of these phenomena are new. Over the last few decades,
neoclassical economics has greatly influenced health care systems
around the world, 2 6 responding to the growing challenge of controlling
health care spending.2 7 As modern welfare states matured, 2"8 and as con-
servative parties gained power and communist systems collapsed, theo-
ries of market based competition played a more direct role in influencing
health care policies.2 9
In the United States in the 1970s and 1980s, pro-market econo-
mists gained influence once health care spending rose as a proportion of
gross domestic product (GDP).2' Theorists and policymakers began ar-
guing under the guise of "consumer sovereignty" that patients should
share a higher burden of their medical bills.2 ' Theories of managed care
tried to constrain the spending by providers.2 Antitrust efforts tried to
reduce the market power of providers and encourage more pure competi-
tion. Physicians became regarded as "providers," patients became
"consumers," and health care became just another business.224
216 Wessen, supra note 84, at 376.
217 Chernichovsky, supra note 18, at 344; Moran, supra note 84, at 17.
218 Marmor, supra note 134, at 7, 11.
219 Wessen, supra note 84, at 376.
220 See Marmor, supra note 84, at 54,54-55.
221 Id. at 56.
222 Id.
223 Id. at 56-57.
224 Id. at 57-60.
680
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Coinciding with the market-based revolution was the cumulative
influence of the American medical system.2 ' For example, other devel-
oped countries have widely adopted pro-market inventions from the
United States, such as the use of diagnosis-related groups (DRGs) to de-
termine the cost of hospital visits.226 Britain, Sweden, and Germany each
reformed their systems based on theories of market competition and effi-
ciency.227 In Europe, these trends accelerated with directives imposed by
the European Commission.
Some observers found this trend to be ironic given the United
States' inability to control its own health care spending.228 In many Eu-
ropean health care systems, policymakers have been reluctant to surrend-
er completely to market competition, given the high priority of protecting
universal access to health care.229
At the same time, multinational institutions like the World Bank,
WTO, W0, and OECD have played a role in promoting greater privati-
zation and commercialization in health care. For example, the WTO has
long sought to privatize and deregulate the health care sectors in many
countries, particularly in the developing world.23 The WTO advocates
eradicating trade barriers, opening health sectors to foreign direct in-
vestment (FDI), and eliminating market failures to encourage competi-
tion.23" ' It has also tried to convince countries to reduce trade barriers in
health care by making commitments under the General Agreement on
Trade in Services (GATS). 232 Only a fraction of GATS signatories have
made such commitments in health care, primarily because they view
health care as a public good.233
Perhaps unsurprisingly, multinational organizations like the
World Bank, OECD, and WHO favor convergence theories in health
care, particularly theories that predict countries will move towards mar-
ket competition. 234 But these positions have been criticized. Some have
225 Wessen, supra note 84, at 376.
226 Id. at 377 (citing Kimberly, de Pouvourville, & Associates, 1993).
227 id.
228 id.
229 Id. at 379.
230 See, e.g., Council for Trade in Services, Background Note by the Secretariat: Health and Social
Services, S/C/W/50 (Sep. 18i 1998), available at
http://www.wto.org/english/tratop-e/serv-e/w50.doc.
231 id.
232 David Price, Allyson M. Pollock, & Jean Shaoul. How the World Trade Organization Is Shaping
Domestic Policies in Health Care, 354 LANCET 1889, 1890 (1999).
233 See Chanda, supra note 110, at 29.
234 Lian, supra note 104, at 307.
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described WTO trade agreements as a "bill of rights for corporate busi-
ness."
2 35
In the United States, organizations like the Department of Com-
merce, the U.S. Trade Representative (USTR), and the Coalition of Ser-
vice Industries continue to push foreign health care sectors to privatize
and remove trade barriers. 36 Other powerful institutions such as the U.S.
Centers for Medicare and Medicaid Services (CMS) and the World Bank
have been lead by pro-market health economists.2 37 The United States
has been the leading source for advocating markets in health care:
The policy history of recent years amounts to "Americanization."
Theories of planned markets, for instance, emerged out of policy de-
bates created by the chaos of the American health care system. Three
decades ago the United States was the "laggard" looking to Europe
for reform inspiration; in the 1990s the traffic has been in the other
direction... 2 8
Yet, the American system has proven ineffective at using market
mechanisms to control costs. Ted Marmor warns that, "[i]t is not clear
what American experience (lagging as it is on coverage and cost control)
can teach others about economy and effectiveness in the delivery of med-
ical care. ' 239 Michael Moran goes further, suggesting that, "[lt]aking les-
sons in health care policy from the United States is like receiving instruc-
tion in seamanship from the crew of the Titanic."2' Indeed, some
believe that developing countries have been pushed by American econ-
omists working for international organizations to adopt pro-competitive
health care markets, leading to reforms that have only widened dispari-
ties in access to health care.24" '
But the privatization and commercialization of health care is
much more than ideology. 242 Health care is a major industry in virtually
every developed country and is becoming a major industry in many de-
veloping countries.243 The products and services that comprise the health
235 Price et al., supra note 232, at 1889.
216 Id. at 1889-90; Council for Trade in Services, supra note 230, at 6, 9.
237 Ranade, supra note 84, at 11.
238 Moran, supra note 217, at 18.
231 Marmor, supra note 218, at 7, 12.
240 Moran, supra note 217, at 19.
241 Mechanic & Rochefort, supra note 4, at 245.
242 Moran, supra note 217, at 19.
243 See generally Anne Mills, Ruairi Brugha, Kara Hanson & Barbara McPake, What Can Be Done
about the Private Health Sector in Low-Income Countries?. 80 BULLETIN OF THE WORLD
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care industry are themselves massive industries, like the pharmaceutical
and medical device industries. 2' Indeed, some commentators have called
health care "the world's biggest industry.""24 Furthermore, it is one of
the most rapidly growing industries in the world.2" Experts expected
worldwide health care spending to grow by $800 billion between 2002
and 2005-from $3.2 trillion to $4 trillion.247 To use one foreboding ex-
ample, as of 2006 the United States spends $2.1 trillion per year on
health care, but is expected to spend $4.1 trillion per year by 2016.248
Of course, the private sector not only benefits from these trends,
but promotes them. Moran describes the health technology industry as a
major driver of markets in the health care sector in the last fifty years.249
He points to the "historical alliance of scientific medicine and industrial
capitalism" that encourages competition through innovation.25° In health
care, the predicate for success is research and development, without re-
gard to how expensive the new technologies will be.251 Because govern-
ments have had difficulty curbing technological innovation, particularly
when it generates income for domestic companies, governments may
have no choice but to embrace at least some forms of commercializa-
HEALTH ORGANIZATION 325 (2002) (discussing the "very large" private health care sectors in
low-income countries).
244 See supra Part 1l.B.3; Moran, supra note 217, at 20 (emphasizing the magnitude and strategic
importance of health care products and services industries).
245 Moran, supra note 217, at 21 (quoting Stephen Jencks & George Schieber, Containing U.S.
Health Costs: What Bullet to Bite?, HEALTH CARE FINANCING REVIEW I (Supp. 1991)).
246 Chanda, supra note 110, at 158.
247 The World Bank estimated that global health spending was $3.2 trillion in 2002. PABLO
GOTTRET & GEORGE SCHIEBER, WORLD BANK, HEALTH FINANCING REVISITED: A
PRACTITIONER'S GUIDE 3 (2006),
http://siteresources.worldbank.org/[NTHSD/Resources/topics/Health-FinancingHFRFull.pdf.
Current estimates surpass $4 trillion. Christine Borger, Sheila Smith, Christopher Truffer, Sean
Keehan, Andrea Sisko, John Poisal & M. Kent Clemens, Health Spending Projections Through
2015: Changes on the Horizon, 25 HEALTH AFFAIRS w61 (2006),
http://content.healthaffairs.org/cgi/content/abstract/25/2/w6l; Chanda, supra note 110, at 158.
248 NAT'L HEALTH STATISTICS GROUP ET AL., NATIONAL HEALTH EXPENDITURES AGGREGATE,
PER CAPITA AMOUNTS, PERCENT DISTRIBUTION, AND AVERAGE ANNUAL PERCENT GROWTH.
BY SOURCE OF FUNDS: SELECTED CALENDAR YEARS 1960-2006 1, available at
http://www.cms.hhs.gov/NationalHealthExpendData/downloads/tables.pdf; John A. Poisal,
Christopher Truffer, Sheila Smith, Andrea Sisko, Cathy Cowan. Sean Keehan, Bridget Dicken-
sheets, Nat'l Health Expenditure Accounts Projections Team, Health Spending Projections
Through 2016: Modest Changes Obscure Part D's Impact. 26 HEALTH AFFAIRS w242 (Feb. 21,
2007), http://content.healthaffairs.org/cgi/content/abstract/26/2/w242.
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tion. 52 Moreover, as Moran notes, these new technology markets have
been global, while health care systems remained largely domestic.253
Medical technology companies, broadly defined, are but one of several
key interests that have appropriated and promoted market ideology in the
health care sector.' Because most of the health care sector is now glob-
al, these pro-market forces feel even more inevitable.
These forces have manifested themselves in domestic policy-
making. In the last several years, an unprecedented number of countries,
at all levels of development, have reformed their health care systems.255
Many have reduced the government's role in providing health care.256
Public programs have gradually reduced health spending, and some are
selling their facilities to private entities.257 Many governments are invit-
ing more private sector participation.258
A growing number of developing countries also view their do-
mestic health care industries as potentially lucrative sources of income.259
For instance, private firms are investing money to increase the number of
private beds in public hospitals." ° As a result, many of these countries
are opening their health care sectors to foreign direct investment for the
first time. 261' They are removing traditional barriers to investment, such
as limiting foreign equity participation, imposing discriminatory taxes,
and enforcing restrictive competition policies.262 Instead, countries have
begun to privatize their health sectors in order to upgrade and modernize
their infrastructure.263 For example, India, Indonesia, Nepal, Maldives,
Sri Lanka, and Thailand have recently opened their health care markets
to foreign investment, 26 which has generated new hospitals, clinics, di-
agnostic centers, nursing homes, and treatment centers.265
212 Id. at 26.
... Id. at 26-27.
254 Id. at 30.
255 Benavides, supra note 158, at 53.
256 Id. at 58.
257 Id. at 54; Chanda. supra note 110. at 159.
258 Benavides, supra note 158, at 54.
259 Id. at 55.
260 Id. at 65-66.
261 Chanda, supra note I 10, at 159.
162 Id. at 159, 161.
263 Richard D. Smith, Foreign Direct Investment and Trade in Health Services: A Review of the Li-
terature, 59 SOC. SC. & MED. 2313. 2315 (2004); Chanda, supra note 110, at 158.
264 Chanda, supra note 110, at 159.
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All these trends are not only evidence of market-driven conver-
gence, but they also create an atmosphere that allows the private sector to
exert greater influence in health care. Thus, privatization and commer-
cialization feed a self-reinforcing cycle of market-driven convergence.2
The more health care becomes private and commercial, the more likely
the private sector will generate international standards. The more these
standards emerge, the more opportunities the private sector has to further
privatize and commercialize health care.
C. THE ARGUMENTS AGAINST CONVERGENCE
Although health care convergence may be "intuitively attrac-
tive," '267 its critics argue that convergence theories tend to oversimplify
the issues, underestimate existing levels of divergence, ignore local con-
ditions, and rely on selective evidence. 68 They argue that, notwithstand-
ing the influence of modern science, the practice of medicine still differs
between countries in various ways.269 Although "medicine benefits from
a certain amount of scientific input, culture intervenes at every step of
the way."27 As Lynn Payer notes, "the choice of diagnoses and treat-
ments is not a science ... the weighing of those benefits and risks will
always be made on a cultural scale.
271
Critics also worry that if the public and private sectors view con-
vergence as inevitable, or even desirable in and of itself, then they might
feel compelled to fall in line, even when convergence is counterproduc-
tive.272 Indeed, convergence "might be a self-fulfilling prophecy" that
266 Of course, international competition may also create incentives for providers to differentiate their
products and services in the market. For example, health care providers in China and India still
market traditional healing techniques that are more difficult to obtain elsewhere. Thus, interna-
tional competition may lead to market segmentation even while standards and practices among
Western-style providers gradually converge.
'67 Blank & Burau, supra note 6, at 267.
268 MICHAEL HOWLETT & M. RAMESH, STUDYING PUBLIC POLICY: POLICY CYCLES AND POLICY
SUBSYSTEMS 107 (1995); Blank & Burau, supra note 6, at 267: Christopher Pollitt, Is the Empe-
ror in His Underwear? An Analysis of the Impacts of Public Management Reform, 2 PUB. MGMT.
181 (2000); see generally Alan Jacobs, Seeing Difference: Market Health Reform in Europe, 23
J. HEALTH POL. POL'Y&L. 1(1998).
269 Field, supra note 3, at 40.
270 LYNN PAYER, MEDICINE & CULTURE: VARIETIES OF TREATMENT IN THE UNITED STATES,
ENGLAND, WEST GERMANY, AND FRANCE 26 (1988); Field, supra note 3, at 40.
271 PAYER, supra note 270, at 154.
272 Blank & Burau, supra note 6, at 265.
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countries pursue to their detriment.273 Critics caution that one size does
not fit all.
Each of these critiques contains a kernel of truth. Convergence
is not inevitable. Diverging practices and standards will always remain.
Evidence of convergence can always be countered by evidence of con-
tinuing divergence. Local cultures do matter.
One poignant example is United HealthCare's effort to export its
managed care programs to South Africa. 74 In 1996, the American com-
pany entered into a joint venture with a South African company to offer
managed care plans.275 By 1998, United had discontinued operations and
divested its share in the joint venture, partly because it mishandled rela-
tions with black physicians there, and partly due to a media backlash
against the United States' negative experience with managed care.27 6 In
fact, the joint venture was accused of "medical imperialism" and "medi-
cal apartheid." '277 Thus, although there were strong market incentives for
both United HealthCare and local companies, the joint venture failed for
political and cultural reasons.27 8 In Mexico, a similarly ambitious HMO
venture led by a group from Harvard University failed as well.279
Nevertheless, the convergence hypothesis was never meant to
ignore local conditions or to imply that unique cultures and histories do
not matter. 8 ° As demonstrated by United HealthCare's experience in
South Africa, local conditions will always affect how health care systems
operate 2 ' and there will always remain some degree of divergence. Most
convergence hypotheses simply suggest that macro trends cause specific
activities to converge. 82 For example, after United HealthCare's failed
joint venture, a separate local company created a successful managed
care business in South Africa.283
Likewise, convergence theories are not meant to be absolute.
Continuing divergence does not have to negate broader trends of conver-
gence. Convergence does not have to be inevitable. In the long term,
273 Id.
274 Gould, supra note 134, at 52.
275 Id. at 61.
276 Id. at 64-65.
277 Id. at 61.
278 See generally id.
279 See Batchelder & McGriff, supra note 134, at 263.
280 Mechanic & Rochefort, supra note 4, at 242.
281 Id.
282 Id.
283 Gould, supra note 274, at 65.
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public programs may successfully counter the trends of privatization and
commercialization. However, recent and ongoing trends reveal that the
private sector is driving international practices and standards to converge
in various health related industries.
Finally, market-driven convergence would not be possible with-
out public sector participation. For example, ICH is a collaboration be-
tween the pharmaceutical industry and government regulators. Medical
education is being standardized at both public and private medical
schools. Supra-governmental organizations like the WHO publish inter-
national practice guidelines representing current best practices for surge-
ries, for example." 4 JCI accreditation would not carry the same weight if
Congress had never made JCAHO accreditation a prerequisite for hospit-
al reimbursement under Medicare. Regulators and policymakers have
helped make market-driven convergence possible.
Yet, in spite of all these counterpoints, there remains significant
evidence of market-driven convergence. Even though it is not inevitable,
or absolute, or purely private in all respects, convergence persists in an
environment characterized by constant improvements in communications
and travel, and sustained efforts to privatize and commercialize health
care.
Il. THE BENEFITS AND BURDENS OF MARKET-
DRIVEN CONVERGENCE
What are the implications of market-driven convergence in
health care? And what are the distinct benefits and burdens of conver-
gence driven by the private rather than the public sector? Part III ex-
plores these questions. I begin in Section A by exploring the benefits of
market-driven convergence before assessing the burdens in Section B.
I conclude that although market-driven convergence can be quite
alluring, particularly as countries enjoy new health care resources, tech-
nologies, and other tangible benefits, policymakers should pay close at-
tention to the perils of further privatizing and commercializing their
health sectors. I also assess the unique position of developing countries
that may confront more acute opportunities and risks when attempting to
conform to foreign standards.
284 Lawrence K. Altman, WH.O. Issues a Checklist to Make Operations Safer, N.Y. TIMES, June 25,
2008, http://www.nytimes.com2008/06/25/health/25surgery.html.
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A. THE BENEFITS OF MARKET-DRIVEN CONVERGENCE
Market-driven convergence in health care is capable of generat-
ing several tangible benefits. First, it can improve efficiency in certain
health care markets and amplify the gains from international trade.
Second, it can improve the quality of health care goods and services by
both accelerating and spreading advancements in medical care. Third,
convergence may give developing countries the rare opportunity to at-
tract new resources into their health care sectors, which they can use to
build infrastructure. Finally, market-driven convergence can enhance
some patients' access to health care goods and services, which may im-
prove patients' choice and autonomy.
1. INCREASED EFFICIENCY AND GAINS FROM TRADE
Converging methods, practices, and standards in the private
health care sector may not only allow various markets to operate more
efficiently, but may reduce barriers to trade and encourage more interna-
tional competition. As Bennett explains, actors often harmonize their
conduct when they acknowledge that they are mutually interdependent
and that everyone benefits by avoiding unnecessary inconsistencies.285
Bennett argues in the context of policy convergence that harmonization
is often driven by intergovernmental and supra-national institutions.286
But in the private sector, this is not necessarily so.
Certainly, such institutions often encourage harmonization. Per-
haps the best example is the International Conference on Harmonization
(ICH), an organization created in 1990 by both pharmaceutical regulators
and industry representatives in the United States, Europe, and Japan.287
As I discuss above, the goal of ICH is to harmonize the scientific and
technical aspects of drug development and regulatory approval.288 Multi-
national pharmaceutical companies have undoubtedly benefited from
harmonized standards for clinical trials and marketing approvals in these
jurisdictions. Similarly, the medical device industry has benefited from
the activities of the Global Harmonization Task Force (GHTF), a parallel
organization composed of regulators and industry representatives from
285 Bennett, supra note 3, at 225.
286 Id.
287 Global Harmonization Task Force (GHTF), http://www.ghtf.org/ (last visited Nov. 28, 2008).
288 Id.
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the United States, the European Union, Canada, Australia, and Japan. 89
Private industry representatives actively work with regulators to harmon-
ize regulatory requirements and industry standards in these jurisdictions.
But harmonization also occurs among individual firms in the
market. As Bennett might say, domestic companies sacrifice their short-
term independence for long-term cooperation.2" Indeed, entire industries
have emerged from the demand for international standardization. For
example, the contract research industry was created in part to meet the
demand for international clinical trials that would satisfy multiple regula-
tors. Contract research organizations (CROs) manage clinical trials for
pharmaceutical companies and have tailored their practices to satisfy
regulators from all over the world, which allows their clients to seek si-
multaneous marketing approvals.29'
The contract research industry barely existed twenty years ago,
but is now a lucrative industry unto itself.292 Pharmaceutical companies
have gradually outsourced their clinical trial functions to "manage costs
by reducing jobs, centralizing R&D, and outsourcing to reduce fixed
costs."2 93 Moreover, smaller biotechnology firms often lack the resources
and internal expertise to manage clinical trials that would support mar-
keting applications in multiple jurisdictions. 94 CROs save money for
pharmaceutical and biotechnology companies by centrally housing ex-
pertise of the regulatory requirements in several countries. In turn, the
largest CROs serve several multinational pharmaceutical companies,
creating de facto industry standards. Thus, by outsourcing clinical trials,
the pharmaceutical industry has driven convergence in the contract re-
search industry. Multinational drug companies prefer harmonized stan-
dards because it saves them time and money during the drug develop-
ment and approval processes, making the industry more efficient. The
entire contract research industry emerged from this demand.
Another striking example of how market-driven convergence
may improve efficiency and generate gains from trade is the growth of
"medical tourism," the phenomenon in which patients travel abroad for
medical treatments. 95 Converging practices among physicians, hospitals,
289 Global Harmonization Task Force (GHTF), http://www.ghtf.org/ (last visited Nov. 28, 2008).
290 Bennett, supra note 3, at 226.
29 1 Rettig, supra note 202, at 129, 135.
292 Id. at 131, 135-36.
293 Id. at 135.
294 Id.
295 See generally Cortez, supra note 212, at 82.
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and even insurers are encouraging patients to price shop for surgeries,
mostly in developing countries.296
In 2005, Segouin observed that medical tourism would greatly
expand "due to the development of global standards of quality and the
rise of the processes of accreditation. '297 That same year, a World Bank
research paper announced that the United States could save at least $1.4
billion annually if only 10 percent of patients traveled overseas for fif-
teen low risk surgeries. 298 The authors, Aaditya Mattoo and Randeep Ra-
thindran, noted that "the upper end of the quality distribution of both pro-
fessionals and hospitals in several developing countries lies well above
the minimum acceptable standards in industrial countries."2" Thus, by
conforming to Western medical standards, several developing countries
now attract significant numbers of foreign patients."° As a result, some
developing countries, such as India, Thailand, and Malaysia, are invest-
ing significant resources to attract customers."°
In fact, Mattoo and Rathindran observed that the lack of confor-
mity in the insurance industry has been a major barrier to trade in the
global market for patients.3" Most private health insurance remains non-
portable, which discourages patients from traveling overseas.3 To date,
most health insurers have been reluctant to pay for treatments overseas
due to diverging standards for health care education, hospitals, medical
licensure, and insurance."
However, as convergence begins to affect these areas, some in-
surance companies are beginning to cover treatments at hospitals that
conform to prevailing Western standards like international hospital ac-
creditation."0 Moreover, both the public and private health care sectors
in destination countries are trying to eliminate barriers to trade by con-
forming their standards and practices.3"
296 id.
297 Segouin, supra note 122, at 277.
298 Mattoo & Rathindran, supra note 112, at 1, 3.
219 Id. at 13.
30 Id. at 12.
301 Cortez, supra note 212, at 90-93.
302 See generally Mattoo & Rathindran, supra note 112; Aaditya Mattoo & Randeep Rathindran,
How Health Insurance Inhibits Trade in Health Care, 25 HEALTH AFF. 358 (2006).
303 Mattoo & Rathindran, supra note 112, at 3.
304 See Cortez, supra note 212, at 82-85, 96-98.
305 See supra Part IH.B.2; Cortez, supra note 212, at 99-101.
306 Cortez, supra note 212, at 82-85 (describing private sector initiatives), 89-95 (describing public
sector initiatives).
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The emerging medical tourism industry is instructive. Not only
do converging practices and standards among providers encourage pa-
tients to price shop, but the potentially enormous gains from trade are
encouraging providers to further harmonize their standards to attract for-
eign patients."° Recognizing how lucrative this market may become,
several governments have partnered with local industry to attract pa-
tients. 8 For example, India, Malaysia, Singapore, and Thailand have
used joint public-private partnerships to promote their medical tourism
industries."° Thus, the private sector is responding quickly and decisive-
ly to patients' and insurers' demand for international standardization.
And the market has even spurred the public sector to act.
Interestingly, the largest remaining barriers to the medical tour-
ism market are things controlled mostly by governments. For example,
patients may be reluctant to travel overseas if they do not trust foreign
regulators to adequately oversee local providers.31° Additionally, patients
might not travel if they do not trust foreign courts to provide adequate
legal recourse from medical negligence.31" ' The lagging public sector
may respond to these incentives. We might see increased regulation of
facilities that attract medical tourists. One industry analyst reports that
two Indian states, Madhya Pradesh and Kerala, have formed "public-
private medical tourism councils to regulate the industry and provide a
forum for addressing complaints and malpractices. '"312 Indian hospitals
and physicians may voluntarily accept more burdensome, Western-style
regulation if it allows them to compete with foreign hospitals. Thus, pri-
vate sector convergence may ultimately encourage the public sector to
follow suit.
Scholars and policymakers should track whether these trends en-
courage a race to the top or a race to the bottom. In either case, market-
driven convergence is making some health care goods and services more
tradable, which should, in theory, reduce barriers to trade and facilitate
international competition.
307 See generally id. at 87.
308 Id. at 89-95.
309 id.
310 Id. at 104-106.
3" Id. at 106-107.
312 Tourism Ministry Plans Price Cap for Foreigners. FIN. EXPRESS, Mar. 24, 2005,1 3.
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2. HIGHER QUALITY GOODS AND SERVICES
The second potential benefit of market-driven convergence is
that it may improve the quality of some health care goods and services.
Industry catchphrases like "best practices" may strike many scholars as
hollow business jargon, but in the health care sector, best practices and
industry standards are more likely to be supported by scientific and clini-
cal evidence than in other industries.
Also, competition among private businesses may lead them to
benchmark each others' practices, creating de facto industry standards.
Because quality matters in health care markets, conforming to industry
standards may be required to compete effectively.
Finally, the diffusion of Western medicine might improve the
overall quality of care in certain pockets of the health industry, particu-
larly in places that do not have the infrastructure or scientific base to
generate these advances alone. Thus, market-driven convergence may,
in theory, improve the quality of certain health care .goods and services.
3. UNIQUE OPPORTUNITIES FOR DEVELOPING COUNTRIES
How does market-driven convergence affect developing coun-
tries with vastly different health care systems and economies? I argue
that convergence may present developing countries with several rare op-
portunities.
First, market-driven convergence may encourage some health
care providers in developing countries to adopt modern medical practices
and technologies. Local providers can essentially import time-tested,
evidence based products and techniques from more advanced countries
without sinking significant local resources into developing these ad-
vancements from scratch. That said, adopting standards and practices
from advanced, modern health care systems may require significant in-
vestments in medical infrastructure. In short, market-driven convergence
may be very expensive for developing countries with scarce health care
resources.
Second, market-driven convergence may allow firms from de-
veloping countries to compete more effectively with firms from devel-
oped countries that have greater business expenses, including higher
wages. For example, as I discuss above, the medical tourism industry is
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booming precisely because a critical mass of providers in developing
countries can offer Western-style health care at third-world prices. 3
Third, market-driven convergence may encourage foreign in-
vestment in the health care sectors of developing countries. As men-
tioned above, several middle-income countries increasingly see the po-
tential profits in their health sectors, which have led many governments
to open their health sectors to foreign direct investment.314 New investors
may inject resources that developing countries can use to build medical
infrastructure and modernize aspects of their health care systems. Of
course, new resources may accrue disproportionately to private sector
entities, ignoring the public sector providers that treat local patients."'
According to the trickle-down theory by Alain Enthoven, gains by the
more lucrative portions of the health sector used by rich patients will ul-
timately promote the quality and availability of goods and services used
by the poor.316 This debate has yet to be settled.
Nevertheless, the potential benefits of market-driven conver-
gence in developing countries are far from certain. Indeed, developing
countries are often lost in these discussions. The considerable body of
comparative health policy literature has largely ignored developing coun-
tries-or has considered them only as an afterthought." 7 Those focusing
on health care in developing countries often focus (justifiably) on urgent
public health issues, such as HIV/AIDS, malaria, and tuberculosis. For-
tunately, a growing number of researchers focus on the private health
care sectors in these countries, including the relationships between the
public and private sectors. 18
The volatile nature of private health care markets in developing
countries makes it exceedingly difficult to predict the effects of market-
driven convergence. So what do we know at this point? In the early
1990s, studies began to show that private sector health care played a
much larger role in developing countries than previous characterizations
313 See supra Part III.A.1.
314 See supra Part ll.B.4.
315 See, e.g., Cortez, supra note 212, at 109-10.
316 Alain Enthoven, On the Ideal Market Structure for Third-Party Purchasing of Health Care, 39
SOC. SC. AND MED. 1413, 1420 (1994).
317 Barbara McPake & Anne Mills, What Can We Learn from International Comparisons of Health
Systems and Health System Reform?, 78 BULL. WORLD HEALTH ORG. 811, 817 (2000).
3 18 For example, Anne Mills and Barbara McPake at the Health Policy Unit in the London School of
Hygiene and Tropical Medicine have published several studies examining private health care
systems in developing countries. See, e.g., id.
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suggested.319 Although virtually every developing country with a func-
tioning government uses some type of public system to finance health
care, a very high proportion of total spending in these countries is paid
out-of-pocket.32 For example, 78 percent of health care spending in In-
dia is uninsured, private, and out-of-pocket.32 ' By comparison, the pro-
portion of out-of-pocket spending in the United States is only 13 per-
cent.322 A major reason for the prevalence of private out-of-pocket
spending in developing countries is that their public health care systems
have inadequate resources.323 Thus, even though most developing coun-
tries purport to offer some sort of universal, comprehensive, and free
health care coverage, the inadequacies of these public systems force pri-
vate citizens to pick up the slack. 24
Yet in developing countries, private sector health care goods and
services may have several advantages over their public sector counter-
parts. First, private sector goods and services may be relatively inexpen-
sive, particularly if providers must offer prices that are affordable to the
local population.325 Second, private sector goods and services may be
more accessible. For example, local citizens that need drugs can simply
buy them in retail shops.326 However, as I discuss below, many of these
private goods and services may be of low quality.327 And of course, the
distinction between "public" and "private" in health care is never neat,
and there is often considerable overlap. 28
But again, health care systems are not monolithic, especially
among developing countries. In the health sphere, "[t]here are important
distinctions between the very poor and the transitional, middle-income
nations. 3 29 For example, the World Bank distinguishes between: "Low
Income Countries" (LICs), such as India and Nigeria, with per capita in-
comes of less than $755; "Lower Middle Income Countries" (LMICs),
such as China, Cuba, and Thailand, with per capita incomes between
319 McPake & Mills, supra note 317, at 812.
320 Mark V. Pauly, Peter Zweifel, Richard M. Scheffler, Alexander S. Preker & Mark Bassett, Pri-
vate Health Insurance in Developing Countries, 25 HEALTH AFF. 369 (2006).
321 Id. at 370.
122 Id. at 371.
323 id.
324 Id. at 370, 372.
325 Mills, et al., supra note 243, at 326.
326 id.
327 Id.
328 Id. at 325.
329 McPake & Mills, supra note 317, at 813.
International Health Care Convergence
$756 and $2,995; and "Upper Middle Income Countries" (UMICs), such
as Brazil, Malaysia, Mexico, and Turkey, with per capita incomes be-
tween $2,996 and $9,265.110 The latter countries obviously have higher
income levels and larger middle classes, but also may have more sophis-
ticated public health care sectors and more developed private sectors."'
For example, higher density urban populations tend to reflect more de-
veloped private health care sectors.332
Thus, although market-driven convergence presents many poten-
tial benefits to developing countries, these benefits are highly uncertain.
Indeed, the potential benefits may depend not only on each country's
specific level of development, but also on the public sector's willingness
to demand a share of the new profits and resources from the private sec-
tor. Moreover, if the private sector providers that benefit from conver-
gence are willing to subsidize the public providers and share new re-
sources, developing countries may capture some of the benefits of
market-driven convergence.
4. ENHANCED CHOICE AND AUTONOMY
What affect will convergence have on individual patients? Cur-
rently, health care in many countries is being influenced by patients' de-
mand to have greater choice among providers and treatment options."'
Market-driven convergence may give patients greater choice and variety.
By making health care goods and services more tradable, con-
vergence should, in theory, increase the number of providers both within
and across jurisdictions. As a result, consumers should be able to shop
among providers offering the same (or at least similar) goods and servic-
es based on price, quality, or both.3" For example, the recent surge in
medical tourism is due in part to increased international competition be-
33) Miguel A. Gonzalez Block & Anne Mills, Assessing Capacity for Health Policy and Systems
Research in Low and Middle Income Countries, HEALTH RES. POL'Y & SYS. (2003),
http://health-policy-systems.com/content/l/l/l.
331 McPake & Mills, supra note 317, at 813.
332 Id.; I Inayat Thayer et al., Private Practitioners in the Slums of Karachi: What Quality of Care
Do They Offer?. 46 SOC. SC. & MED. 1441 (1998) (pointing to the proliferation of private doc-
tors in the slums of Karachi, Pakistan).
333 Mechanic & Rochefort, supra note 4, at 259.
334 See generally Cortez, supra note 212.
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tween providers that can offer roughly the same services.335 Patients are
more willing than ever to explore new treatment options overseas.336
Market-driven convergence may also enhance choice and auton-
omy for patients who face long waiting lists in countries with national or
social health insurance systems.337 For example, British patients now
travel to India or to less developed European countries like Turkey for
medical treatments.338 Some public health systems have even embraced
health travel. EU regulations require Member States to reimburse citi-
zens for the medical treatments they receive in other Member States if
there is an "undue delay" in obtaining the procedure domestically.339
Under these regulations, the European Court of Justice recently required
Britain's National Health Service (NHS) to reimburse a British resident
for a hip replacement she obtained in France, even though she did not re-
ceive prior approval from the NHS to seek treatment there.3" In 2004,
the NHS actually began sending patients to France, Spain, and Germany
for certain surgeries to reduce waiting times.341 Without at least some
converging standards between these countries, such efforts would not be
possible.
Finally, market-driven convergence may increase the autonomy
of patients by allowing them to "vote with their feet."' -" 2 Local laws may
ban certain medical treatments. 3  Local regulators may decide that a
treatment is unsafe or not effective.' Or local providers may choose not
335 See generally id.
336 See generally id.
331 Id. at79, 111-13.
338 Record Numbers Go Abroad for Health Treatment with 70,000 Escaping NHS, DAILY MAIL
ONLINE (U.K.), Oct. 28, 2007, http://www.dailymail.co.uk/news/article-490233/Record-
numbers-abroad-health-treatment-70-000-escaping-NHS.html.
339 See Council Regulation 1408/71, art. 22, 1971 O.J. SPEC. ED. (L 149) 2; see generally Council
Regulation 574/72, 1972 O.J. SPEC. ED. (L 74) 1 (the implementing regulation for 1408/71): Ka-
trien Kesteloot, Sabrina Pocceschi & Emmanuel van der Schueren, The Reimbursement of the
Expenses for Medical Treatment Received by "Transnational" Patients in EU-Countries, 33
HEALTH POL'Y 43, 45 (1995).
140 Case C-372/04, The Queen v. Bedford Primary Care Trust & Sec'y of State for Health, 2006
E.C.R. 1-4376; see Mattoo & Rathindran, supra note 112, at 6.
341 Mattoo & Rathindran, supra note 112, at 12 (citing data from the U.K Dep't of Health,
http://www.performance.doh.gov.uk/waitingtimes/index.htm).
342 Cortez, supra note 212, at 111-113. Although this phrase is most often associated with the Tie-
bout Hypothesis, it does not come from Tiebout himself. See Christopher Serkin, Big Differenc-
esfor Small Governments: Local Governments and the Takings Clause, 81 N.Y.U. L. REV. 1624,
1662 n.147 (2006) (citing Todd E. Pettys, The Mobility Paradox, 92 GEO. L.J. 481, 482 n.10
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to provide certain treatments for moral or ethical reasons.5 Market-
driven convergence gives patients the option of obtaining these treat-
ments in other jurisdictions, enhancing their autonomy by allowing them
to vote with their feet. 4 6
B. THE BURDENS OF MARKET-DRIVEN CONVERGENCE
Despite the tangible benefits of market-driven convergence,
there are usually risks in relinquishing control to private markets in
health care. Health care is not like other goods or services. There will
almost never be "perfect" competition in health care markets. 47 Health
care is beset by market failures, some of which are unique to health care,
and some of which cannot be easily cured by government intervention.
For example, most countries view health care as a "public good" not
suitable for privatization or commercialization.s Health care is also no-
torious for the information asymmetries between patients, providers, and
insurers that distort competition.349 Monopolies and monopsonies further
distort prices and incentives." Thus, if health care practices and stan-
dards are converging, and if this is indeed being driven by markets, then
we should be aware of how the market often fails in health care.
This section analyzes two separate dangers of market-driven
convergence. First, convergence may have negative distributive conse-
quences, particularly in developing countries. And second, market-
driven convergence may actually depress the quality of goods and ser-
vices available to low-income patients.
141 Id. at 78.
346 Id. at 111-13.
341 Council for Trade in Services, Background Note by the Secretariat: Health and Social Services,
S/C/W/50 (Sept. 18, 1998), http://www.wto.org/english/tratop_e/serv-e/w50.doc (even the pro-
market World Trade Organization acknowledges the inherent market failures in health care:
"Health services are normally provided in an environment significantly different from the
textbook ideal of a market economy. A host of imperfections, distortions and information
problems may prevent consumers and producers from contracting on an equal basis, in full
knowledge of, and financial responsibility for, the ensuing results.").
348 Chanda, supra note 110, at 29.
349 Chernichovsky, supra note 18, at 344-45; Hall & Schneider, supra note 91, at 647-48.
350 Chemichovsky, supra note 18. at 34445; Hall & Schneider, supra note 91, at 647-48. A "mo-
nopsony" is a market dominated by a single buyer, or a single source of demand, and is the coun-
terpoint to a "monopoly," which is a market dominated by a single seller, or a single source of
supply. BLACK'S LAW DICTIONARY, 1028 (8th ed. 2004).
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1. CONVERGENCE MAY HAVE NEGATIVE DISTRIBUTIVE
CONSEQUENCES
Perhaps the most obvious danger of market-driven convergence
is that increased privatization and commercialization in health care will
exacerbate unequal access to care and other distributive concerns. Al-
though countries looking to conform to international standards might be
justifiably proud to generate new revenues, build new facilities, and offer
new technologies, these countries should consider the risks of further
privatizing and commercializing their health sectors.35
The risks may be particularly acute for developing countries with
less robust public health care systems. Developing countries may be
more desperate to attract new financial resources or find new ways to
provide health care to their citizens. A major risk is that conforming to
international practices will exacerbate the two tiered health care systems
in some countries, with separate systems for the wealthy and the poor.352
Market-driven convergence may cause more resources to be devoted to
private sector providers that cater to wealthier populations, resulting in
fewer resources being dedicated to the public facilities that treat most cit-
izens. For example, private hospitals in developing countries increasing-
ly capture high revenue patients, leaving public hospitals with fewer re-
sources to care for those who can't afford private hospitals.353 In Brazil,
the private sector uses 120,000 physicians to treat 25 percent of Brazil's
population; the public sector uses less than 70,000 physicians to treat the
remaining 75 percent of the population.3 54
Health insurance is also susceptible to this public-private imbal-
ance. Private health insurers may "cream-skim." '355 When public insur-
ers have to compete with private insurers for patients, the private sector
tends to gobble up the "healthier and wealthier," while the public sector
is left to care for the poorest and sickest. 56 In many countries, the pri-
35' Smith, supra note 263, at 2320.
352 Mechanic & Rochefort, supra note 4, at 249.
353 Sarah Sexton, Trading Health Care Away: GATS, Public Services, and Privatisation. CORNER
HOUSE BRIEFING 1, 19-20 (2001), http://www.thecornerhouse.org.uk/pdfgbriefing/23gats.pdf.
... Id. at 28.
355 Wynand P.M.M. van de Ven et al., Access to Coverage for High-Risks in a Competitive Individ-
ual Health Insurance Market: Via Premium Rate Restrictions or Risk-Adjusted Premium Subsi-
dies?, 19 J. HEALTH ECON. 311, 316 (2000) (defining the practice of cream skinning); Timothy
Stoltzfus Jost, Private or Public Approaches to Insuring the Uninsured: Lessons from Interna-
tional Kcperience ivith Private Insurance, 76 N.Y.U. L. REV. 419, 458-59 (2001).
356 Sexton, supra note 353, at 25.
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vate sector benefits from the public safety net catching the least profita-
ble patients.
The second danger of market-driven convergence is that market
failures may be more severe in lesser developed countries. For example,
information asymmetries may be much more pronounced in poorer coun-
tries,357 where consumers may be less educated and may have less access
to information. Many local citizens in developing countries may lack ba-
sic knowledge about diseases and treatment options, which can artificial-
ly depress demand for beneficial treatments.358 Some observers warn that
because such citizens depend greatly on their health care providers for
information, they are particularly vulnerable to "self-interested behavior
by providers."359
Notwithstanding these unique difficulties, international organiza-
tions have long encouraged developing countries to further privatize and
commercialize their health care sectors. The World Bank and the Inter-
national Monetary Fund (IMF) have been criticized for forcing develop-
ing countries to privatize their health care sectors.3" Sarah Sexton argues
that World Bank and IMF reforms:
have helped commercial interests to cater to wealthier people in de-
veloping countries through private health care insurance and private
hospitals. Most people are left dependent on a poorly equipped,
shrinking public sector; it is the affluent who call upon rapidly ex-
panding and increasingly high-cost private services.
36
'
Moreover, although free trade agreements, such as GATS, ap-
pear to have minimal impact in the health sector, 62 some worry that
GATS could be used to force developing countries to align their health
policies at the expense of domestic needs.363 For example, GATS encou-
rages WTO members to liberalize free trade by requiring each WTO
country to treat all countries alike (so-called "most favored nation" sta-
357 McPake & Mills, supra note 317, at 813 (noting the prevalence of information asymmetries in
health care).
358 Mills et al., supra note 243, at 326.
359 id.
360 Sexton, supra note 353. at 14; Kasturi Sen & Meri Koivusalo, Health Care Reforms and Devel-
oping Countries-A Critical Overview, 13 INT'LJ. HEALTH PLAN. & MGMT. 199-215 (1998); see
generally Mechanic & Rochefort, supra note 4, at 251.
361 Sexton, supra note 353, at 15.
362 Id. at 14 (noting that many countries have not committed to liberalizing trade in their health care
sectors under GATS).
363 Blank & Burau, supra note 6, at 267; Leah Belsky et al., The General Agreement on Trade in
Services: Implications for Health Policymakers, HEALTH AFF. May-June 2004, at 137, 137-38;
see generally Sexton, supra note 353, at 1, 16, 18-20.
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tus) and to treat foreign companies as if they were domestic ("national
treatment").3" As a result, local health care providers may struggle to
compete with foreign providers for scarce resources. Other critics of
GATS worry that market-driven health care systems reduce widespread
access to health care, as observed in the United States and in many Latin
American countries.365
In fact, several international observers worry that these market
reforms will create international convergence towards the U.S. health
care system, which is dominated by for-profit, private sector compa-
nies.36 It is easy to understand the cause for concern. The U.S. health
care system is famous for its spending, accounting for roughly half of the
$4 trillion spent on health care each year worldwide.3 67 But by most es-
timates, Americans are neither healthier nor happier with their health
care system than citizens in peer countries.36 Moreover, the United
States has not proven that market mechanisms can effectively control
health care spending.369
American medicine is exceptional in other ways that developing
countries might not want to emulate. It is aggressive.37 ° For example,
American physicians order several times as many hysterectomies, cesa-
rean sections, and coronary bypasses than their counterparts in other in-
dustrialized countries.37' American medicine is extremely specialized.
Specialty providers in the United States have proliferated,372 and some
worry that American medicine has become too specialized and relies too
heavily on "high technology." '373 Mark Field quotes a British physician
who calls Americans "Godsakers," which means: "For God's sake, do
314 Uruguay Round Agreement: General Agreement on Trade in Services, Annex I B, Apr. 15, 1994,
1869 U.N.T.S. 183 (most-favored nation provisions are located at GATS Article II, and national
treatment provisions are located at Article XVII); Sexton, supra note 353, at 4.
365 Sexton, supra note 353, at 1.
366 Id. at 20.
161 Id. at 27.
368 Gerard F. Anderson et al., It's the Prices Stupid: Why the United States Is So Different front Oth-
er Countries, HEALTH AFF., May-June 2003, at 89, 103; Timothy Stolzfus Jost, Our Broken
Health Care Systen and How to Fix It: An Essay on Health Law and Policy, 41 WAKE FOREST
L. REV. 537, 538 (2006); Gerard F. Anderson et al., Health Spending in the United States and the
Rest of the Industrialized World, 24 HEALTH AFF. 903, 909 (2005).
369 Moran, supra note 217, at 19.
370 Field, supra note 3, at 41.
171 Id. at 40-41.
172 Id. at 39.
373 John D. Stoeckle, The Citadel Cannot Hold: Technologies Go Outside the Hospital, Patients,
and Doctors Too, MILBANK Q., 1995, at 3.3-4.
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something!"374 More than in other countries, American physicians and
patients tend to think that more medical intervention is usually better.375
Ironically, evidence is emerging that increasingly expensive pri-
vate insurance in the United States is driving people into public pro-
grams, even if they remain eligible for private, employer sponsored in-
surance.376 Thus, market-driven convergence may Americanize health
care in countries that can least afford it. Policymakers in these countries
might consider limiting public expenditures on unproven new technolo-
gies or investing more resources into basic, primary care services. Poli-
cymakers might also permit aggressive new technologies in the private
sector but find ways to cross subsidize basic care in the public sector.
Finally, market-driven convergence may be a self-reinforcing
cycle that tends to promote further privatization and commercialization
in health care, which may not be sustainable for many countries. A
growing consensus recognizes that public health care systems get more
bang for their buck, tend to be more equitable, and are generally superior
at controlling costs than private systems.377 Dov Chernichovsky notes
that "[a]lthough private enterprises may have greater incentive to operate
more efficiently than their public counterparts," they also tend to gener-
ate monopolies, prevent economies of scale, and impose "high informa-
tion and transactional costs on the consumers, insurers, and even the care
providers." '378
Everyone in a private system has to fend for herself. Consumers
must either pay out of pocket or choose among different health insurance
premiums, deductibles, and a maze of insurer specific rules. Consumers
must also choose providers, research treatment options, and budget their
present and future spending. Insurers must contract with providers, de-
termine what services they will pay for, negotiate prices, and navigate a
complex web of national and local regulations. Finally, health care pro-
viders must negotiate with payors and comply with increasingly complex
regulatory schemes. Not all of these hurdles disappear in a public sys-
tem, particularly in models that publicly finance private providers. But a
substantial chunk of these hurdles do subside in the public realm. Mar-
374 Field, supra note 3, at 41.
375 id.
376 Jessica P. Vistnes & Barbara S. Schone, Pathways to Coverage: The Changing Roles of Public
and Private Sources, 27 HEALTH AFF. 44,45-46 (2008).
377 Chernichovsky, supra note 18, at 344.
371 Id. at 345.
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ket-driven convergence might exacerbate these inefficiencies by shifting
more activities to the private sector.
The trick for policymakers is capturing the tangible benefits of
market-driven convergence without exacerbating existing inequalities
and inefficiencies. Recognizing where and how the market fails is cru-
cial. Again, policymakers in nearly all jurisdictions are struggling to find
the right balance.
2. CONVERGENCE MAY LOWER THE QUALITY OF HEALTH CARE
Critics of privatization argue that for-profit health care is not on-
ly more expensive and less efficient than publicly provided care, but that
it is also of lesser quality.379 A common criticism is that companies
create artificial demand for their medical goods and services, even
though new products may provide little if any marginal benefit over pre-
vious technologies and may also pose unknown risks.38°
Of course, there are several reasons why private sector health
care goods and services may be of relatively poor quality in developing
countries. First, observers have already found that the quality of private
health care goods and services in developing countries can be low. 8' For
example, many citizens in developing countries pay for most of their
health care services out-of-pocket, and these transactions have been as-
sociated with "adverse health and financial consequences." '382 Second,
many lower tiered private providers receive no guidance from the public
sector on how to diagnose or treat common ailments, so their practices
may be influenced more by information distributed by self-interested
parties, such as pharmaceutical companies.383 Third, lower tier private
providers may also lack access to adequate resources, such as essential
diagnostic or treatment equipment.3" It is not uncommon for local pro-
viders to use treatments that they know are ineffective because unin-
formed local citizens demand them.85 Finally, many developing coun-
tries have witnessed the growth of relatively large "informal" private
379 Sexton, supra note 353, at 25 (citing studies comparing public and private providers in the Unit-
ed States and other countries).
380 Mechanic & Rochefort, supra note 4, at 243-44; Mechanic, supra note 2, at 46.
38' Mills et al., supra note 243, at 326.
382 Pauly et al., supra note 320, at 373.
383 Mills et al., supra note 243, at 327.
384 Id.
3s5 Id.
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health sectors, which are much less regulated and may offer products and
services of widely varying quality.
Compounding these problems, few consumers in developing
countries have the requisite knowledge or information to identify higher
quality goods and services.386 Wider information asymmetries between
consumers and providers produce more dramatic market failures-
consumers may neither seek nor receive high quality care.387 Neverthe-
less, governments can help even a relatively uneducated population iden-
tify quality care by sponsoring educational campaigns and playing a role
in accreditation and credentialing. 88
Patients in developing countries may also lack adequate oppor-
tunities to seek redress when they have been harmed by health care pro-
viders or products.389 For example, India created the Consumer Protec-
tion Act in 1986 to provide stronger remedies to consumers,3" but many
perceive these protections to be inadequate.39' This may reflect similar
sentiments in other jurisdictions. Yet, as the private health care sectors
grow in these countries, it may become more difficult to regulate private
providers. Researchers suggest that the window of opportunity may be
small for developing countries to regulate the private sector effectively
before it becomes too powerful economically and politically.392 Market-
driven convergence may not only accelerate the growth of the private
sector, but might also empower foreign companies that can lobby more
effectively to avoid stringent regulation.
In turn, there are several discrete risks in allowing the private
sector to drive international standards and push for further privatization
and commercialization in health care. Although immediate solutions
may prove to be evasive, policymakers should think about how interna-
tional market competition might affect their domestic health care pro-
grams. Finding ways to cross subsidize the public sector might be the
best way to reap the tangible benefits of market-driven convergence
without surrendering too much control to the private sector or allowing it
to exacerbate existing inequalities.
386 McPake & Mills, supra note 317, at 813; Mills et al., supra note 243, at 327.
387 Mills et al., supra note 243, at 326.
388 Id. at 327.
389 id.
390 The Consumer Protection Act, 1986, No. 68, Acts of Parliament, 1986, available at
http://ncdrc.nic.in; Mills et al., supra note 243, at 327.
391 Ramesh Bhat, Regulating the Private Health Care Sector: The Case of the Indian Consumer
Protection Act, 11 HEALTH POL'Y & PLAN. 265, 272-275 (1996).
392 Mills et al.. supra note 243, at 328 (citing the experience in Thailand).
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CONCLUSION
In this article, I showed how recent international trends in health
care derive in part from market-driven convergence-the process by
which the private sector has encouraged methods, practices, and stan-
dards in the health care industry to become more alike across jurisdic-
tions. Relying on over thirty years of scholarship, I explained how mar-
ket-driven convergence is a dynamic, self-reinforcing process. I also
showed how convergence allows physicians to migrate, hospitals to open
branches overseas, pharmaceutical companies to sell prescription drugs
around the world, and patients to travel for surgeries. These trends dem-
onstrate not only the power of market-driven convergence, but also its
self-reinforcing nature.
I also showed that though market-driven convergence may gen-
erate tangible benefits for many, these benefits tend to accrue dispropor-
tionately to the private sector and may undermine public health care pro-
grams. Finally, I demonstrated the perils of emulating the American
health care system and adopting its market based principles, particularly
for developing countries that may not only be more keen to adopt these
approaches, but also more susceptible to their dangers. Policymakers in
all countries should recognize the risks and byproducts of market-driven
convergence.
